2010 Annual Meeting | Poster Session 06

Date Thursday 04/15/10

Time 03:00 PM - 07:30 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Scientific Poster Session

Topic(s) Cerebrovascular Disease and Interventional Neurology, Neuro-oncology, Neuro-ophthalmology/Neuro-otology, Aging and Dementia, Headache, MS and Related Diseases, Muscle Disease/Neuromuscular Junction, Neuroepidemiology/Health Services and Outcomes Research, Neurogenetics and Gene Therapy, Neurologic �鶹��ýӳ��, Neurotoxicology, Peripheral Nerve

CME Available No CME available

Event Timeline
03:00 PM - 04:30 AM		Break
03:00 PM - 07:30 PM	Abstract	001 - Acute Kidney Injury Is Associated with Hospital Mortality after Acute Ischemic Stroke, but Not Intracerebral Hemorrhage
03:00 PM - 07:30 PM	Abstract	002 - Depressive Symptoms and Incidence of First Stroke: Does Stroke Risk Decline after Depressive Symptoms Resolve?
03:00 PM - 07:30 PM	Abstract	003 - Incidence of Cerebral Venous Thrombosis in United States: 2002-2006. A National Analysis
03:00 PM - 07:30 PM	Abstract	004 - Endocarditis Is a Common Stroke Mechanism in Hemodialysis Patients
03:00 PM - 07:30 PM	Abstract	005 - Low Rates of Blood Pressure Goal Achievement among Minorities with Stroke and Coronary Artery Disease Are Not Due to Less Aggressive Treatment
03:00 PM - 07:30 PM	Abstract	006 - Physical Activity and Functional Outcome from Stroke
03:00 PM - 07:30 PM	Abstract	007 - Should ICH Outcome Prediction Models Be Modified in African Americans?
03:00 PM - 07:30 PM	Abstract	008 - Load of Myocardial Infarction and Risk of Brain Infarction: The AGES-Reykjavik Study
03:00 PM - 07:30 PM	Abstract	009 - The Northern Manhattan Study Global Vascular Risk Score Is Associated with Leukoaraiosis
03:00 PM - 07:30 PM	Abstract	010 - Newly Diagnosed Diabetes Portends a Poor Outcome for Acute Stroke Patients Regardless of the Subtype
03:00 PM - 07:30 PM	Abstract	011 - Chocolate Consumption and Risk of Stroke
03:00 PM - 07:30 PM	Abstract	012 - Seasonal Variation of Stroke in Relation to Influenza Infection
03:00 PM - 07:30 PM	Abstract	013 - Trends in Outcome and Hospitalization Cost among Adult Patients with Acute Ischemic Stroke in the United States
03:00 PM - 07:30 PM	Abstract	014 - Accuracy of the New ICD-9 Code for "Drip-and-Ship" Thrombolytic Treatment in Patients with Acute Ischemic Stroke
03:00 PM - 07:30 PM	Abstract	015 - Racial and Geographic Differences in Fish Consumption: The REasons for Geographic and Racial Differences in Stroke (REGARDS) Study
03:00 PM - 07:30 PM	Abstract	016 - Stroke-Associated Pneumonia (SAP): Do Academic and Community Hospitals Have Similar Incident Risk and Outcomes?
03:00 PM - 07:30 PM	Abstract	017 - Prevalence of Thyroid Abnormalities and Associations with Cerebrovascular Disease in a Nationwide Survey
03:00 PM - 07:30 PM	Abstract	018 - Pronounced Association of Elevated Serum Homocysteine with Stroke in Subgroups of Individuals: A Nationwide Study
03:00 PM - 07:30 PM	Abstract	019 - Impact of Microalbuminuria on Incident Stroke Risk: A Meta-Analysis
03:00 PM - 07:30 PM	Abstract	020 - Incidence of First Stroke in a Total Population Study
03:00 PM - 07:30 PM	Abstract	021 - Distal Myopathies: A Retrospective Study of 28 Cases
03:00 PM - 07:30 PM	Abstract	022 - Progressive Dysphagia in Limb Girdle Muscular Dystrophy Type 2B: An Extension of the Clinical Phenotype
03:00 PM - 07:30 PM	Abstract	023 - Oculopharyngodistal Myopathy Is a Distinct Entity - Clinical and Genetic Characterization of 40 Turkish OPDM Patients
03:00 PM - 07:30 PM	Abstract	024 - Dominant Cardiomyopathy and Very Distal Myopathy with Rod, Myofibrillar and AVSF Myopathology
03:00 PM - 07:30 PM	Abstract	025 - Hereditary Myopathy with Early Respiratory Failure (HMERF) - A Uniform Clinical Phenotype with Several Possible Genotypes
03:00 PM - 07:30 PM	Abstract	026 - Non-GNE Related Quadriceps Sparing Myopathy: A Case Report
03:00 PM - 07:30 PM	Abstract	027 - Scoliosis Surgery (ScSu) in Respiratorily-Compromised Congenital Neuromuscular Patients Can Fatally Worsen Ventilatory Function or Engender Nocturnal BiPAP Dependency, as Evidenced in Four Children with Focal-Loss-of-Cross-Striations (FLCS)
03:00 PM - 07:30 PM	Abstract	028 - Sparing of Myofiber Membranes in Infantile Pompe's Disease: Dissociated Excitation-Contraction Coupling
03:00 PM - 07:30 PM	Abstract	029 - Clinical Methodology and Outcome of Enzyme Replacement Therapy in a Series of Late-Onset GSDII Patients
03:00 PM - 07:30 PM	Abstract	030 - Analysis of Cardiac Involvement in Children and Adults with Pompe Disease from the Pompe Registry
03:00 PM - 07:30 PM	Abstract	031 - Enzyme Replacement Therapy in Five Adults with Late-Onset Pompe Disease
03:00 PM - 07:30 PM	Abstract	032 - Characterization of Non-Length-Dependent Small Fiber Sensory Neuropathy
03:00 PM - 07:30 PM	Abstract	033 - Natural History of Idiopathic Small and Large Fiber Polyneuropathy: A Retrospective Study
03:00 PM - 07:30 PM	Abstract	034 - Sensory Neuropathy in Patients with Cryoglobulin Negative Hepatitis-C Infection
03:00 PM - 07:30 PM	Abstract	036 - Peripheral and Central Large Fiber Dysfunction in Idiopathic Hyperhomocysteinemia
03:00 PM - 07:30 PM	Abstract	037 - Lower Extremity Weakness and Dysesthesias Associated with Zinc Deficiency
03:00 PM - 07:30 PM	Abstract	038 - The Pathological Characterization of Peripheral Neuropathy in Copper Deficiency
03:00 PM - 07:30 PM	Abstract	039 - Statin Toxicity for Sensory Neurons In Vitro: Mechanism of Action Distinct from Cholesterol Synthesis
03:00 PM - 07:30 PM	Abstract	040 - Sensori-Motor CMT "Like" Neuropathy with Ataxia Ophtalmoplegia and Dysarthria in Moroccan Patient with Homozygote POLG Mutation
03:00 PM - 07:30 PM	Abstract	041 - SCA3 Presenting as an Isolated Axonal Polyneuropathy
03:00 PM - 07:30 PM	Abstract	042 - Impaired Neurovascular Repair in Subjects with Diabetes Following Intracutaneous Axotomy
03:00 PM - 07:30 PM	Abstract	043 - MNSI, Electrophysiologic and Epidermal Nerve Fiber Density Findings in Cryptogenic Sensory Polyneuropathy Compared to Diabetic Polyneuropathy and Normal Controls
03:00 PM - 07:30 PM	Abstract	044 - Is Clinically Diagnosed Diabetic Peripheral Neuropathy Predominantly Metabolic or Vascular in Origin?
03:00 PM - 07:30 PM	Abstract	045 - Electrodiagnostic Features of CIDP in Diabetes Mellitus
03:00 PM - 07:30 PM	Abstract	046 - Type 2 Diabetes Mellitus Exacerbates Neuropathy in Patients with CMT1a
03:00 PM - 07:30 PM	Abstract	047 - Epidemiology of Peripheral Neuropathy (PN) in a Tertiary Neuromuscular Disease Clinic in Northeast Brazil
03:00 PM - 07:30 PM	Abstract	048 - Multi-Factorial Analysis of Risk Factors for the Development of Peripheral Neuropathy
03:00 PM - 07:30 PM	Abstract	049 - Dizziness and Loss of Balance in Diabetics: The Relative Contribution of Vestibular vs. Somatosensory Dysfunction; Implications for Therapeutic Intervention
03:00 PM - 07:30 PM	Abstract	050 - Effects of Brief Supervised Exercise Program on Diabetic Neuropathy
03:00 PM - 07:30 PM	Abstract	051 - Timed Vibration Predicts Progression to Symptomatic Neuropathy in Diabetic Subjects
03:00 PM - 07:30 PM	Abstract	052 - Acute Motor Axonal Neuropathy Presenting with Ventral Horn and Proximal Root Involvement: A Case Report and Review of the Literature
03:00 PM - 07:30 PM	Abstract	053 - Guillain-Barre Syndrome after Influenza Vaccination in the United States. A Report from the CDC/FDA Vaccine Adverse Event Reporting System. (1990-2009)
03:00 PM - 07:30 PM	Abstract	055 - Guillain-Barre Syndrome after Hepatitis Vaccination in the United States. A Report from the CDC/FDA Vaccine Adverse Event Reporting System. (1990-2009)
03:00 PM - 07:30 PM	Abstract	056 - Guillain-Barre Syndrome after GARDASIL Vaccination in the United States. A Report from the CDC/FDA Vaccine Adverse Event Reporting System. (2006-2009)
03:00 PM - 07:30 PM	Abstract	057 - Acute Motor Conduction Block Neuropathy (AMCBN): Review of Eleven Cases
03:00 PM - 07:30 PM	Abstract	058 - Anti-Ganglioside Antibodies in Guillain-Barr[eacute] Syndrome Patient Sera Activate Small GTPase RhoA
03:00 PM - 07:30 PM	Abstract	059 - Preciding Infections, the Spectrum of Morbidity and Outcome of Guillain-Barr[eacute] Syndrome in the Intensive Care Unit
03:00 PM - 07:30 PM	Abstract	060 - Case of Recurrent Guillain-Barr[eacute] Syndrome with Three Episodes
03:00 PM - 07:30 PM	Abstract	061 - Rituximab in Polyneuropathies with Anti-MAG Antibodies: Efficacy, Tolerance and Predictive Factors of Response to Treatment
03:00 PM - 07:30 PM	Abstract	062 - Cauda Equina Hypertrophy with Abundant Onion Bulb Formation Presenting as a Lower Motor Neuron Syndrome
03:00 PM - 07:30 PM	Abstract	063 - Chronic Inflammatory Demyelinating Polyneuropathy Disease Activity Status (CDAS): Recommendations for Clinical Research Standards
03:00 PM - 07:30 PM	Abstract	064 - A Randomized Controlled Trial Comparing Two Different IV Immunoglobulins in CIDP (CIC-Study)
03:00 PM - 07:30 PM	Abstract	065 - Real World Use of IVIg in CIDP: Assessment of Utilization across the Scope of Practice
03:00 PM - 07:30 PM	Abstract	066 - Proteonomic Analysis of Amyloid-Like IgM Neuropathy in Waldenstrom's Macroglobulinemia
03:00 PM - 07:30 PM	Abstract	067 - Increased Frequency of HLA-DRB1*15 in Patients with Multifocal Motor Neuropathy
03:00 PM - 07:30 PM	Abstract	068 - Autonomic Dysfunction in Chronic Inflammatory Demyelinating Polyradiculoneuropathy
03:00 PM - 07:30 PM	Abstract	069 - Non-Myeloblative Autologous Hematopoietic Stem Cell Transplantation for Chronic Inflammatory Demyelinating Neuropathy (CIDP) Treatment
03:00 PM - 07:30 PM	Abstract	070 - Interest of Intensive Intravenous Immunoglobulins (IVIG) Regimen in CIDP Partially IVIg Responders
03:00 PM - 07:30 PM	Abstract	071 - Clinical Characteristics and Potential Therapeutic Implications of Inflammatory Pseudotumor of Nerve
03:00 PM - 07:30 PM	Abstract	072 - Inflammatory Post-Surgical Neuropathy
03:00 PM - 07:30 PM	Abstract	073 - Anterior Interosseous Nerve Syndrome Following Procedures
03:00 PM - 07:30 PM	Abstract	074 - Phrenic Nerve Pacemaker for Isolated Diaphragmatic Palsy in Neuralgic Amyotrophy
03:00 PM - 07:30 PM	Abstract	075 - Phrenic Neuropathies: A Clinical and Electrodiagnostic Study
03:00 PM - 07:30 PM	Abstract	076 - The Timing and Distribution of Triggers among 268 Bouts of Neuralgic Amyotrophy
03:00 PM - 07:30 PM	Abstract	077 - Hold Your Arms High Traction Lesions of the Brachial Plexus in Bodyflying
03:00 PM - 07:30 PM	Abstract	078 - High-Dose Intravenous Steroids in Definite or Suspected Immune-Mediated Neuropathies
03:00 PM - 07:30 PM	Abstract	079 - Predictors of Positive Nerve Biopsies in Presumed Vasculitis
03:00 PM - 07:30 PM	Abstract	080 - Hereditary Neuropathy with Pressure Palsies: Analysis of 24 De Novo Unrelated Cases
03:00 PM - 07:30 PM	Abstract	081 - Disparities in the Diagnosis of Duchenne and Becker Muscular Dystrophy: Data from the MDSTARnet, 1999-2007
03:00 PM - 07:30 PM	Abstract	082 - Respiratory Care Trends for Duchenne and Becker Muscular Dystrophies (DBMD): Data from the MD STARnet, 2001-2007
03:00 PM - 07:30 PM	Abstract	083 - Clinical and Electrophysiological Features in Fifty-Eight Chilean Children with Guillain-Barr[eacute] Syndrome
03:00 PM - 07:30 PM	Abstract	084 - Impact of Botulinum Toxin Type A (BoNTA) on Health Utility in Patients Receiving Treatment for Approved Therapeutic Indications: Interim Analysis of a Large Ongoing Phase IV Prospective Observational Cohort Study (MDs on BOTOX[reg] Utility-Mobility) in Canada
03:00 PM - 07:30 PM	Abstract	085 - Evaluation of Quality of Life in Korean Charcot-Marie-Tooth Disease Patients
03:00 PM - 07:30 PM	Abstract	086 - Caregiving Parents of Children with Neuromuscular Conditions: Experiences of Stress and Personal Growth
03:00 PM - 07:30 PM	Abstract	087 - Baseline Characteristics of Patients Receiving Botulinum Toxin Type A for Approved Therapeutic Indications in a Large Ongoing Phase IV Prospective Observational Cohort Study (MDs on BOTOX[reg] UTILITY - MOBILITY) in Canada
03:00 PM - 07:30 PM	Abstract	088 - Edge Motion Technology To Detect Abnormalities of Gait and Balance
03:00 PM - 07:30 PM	Abstract	089 - Dual-Task Related Gait Changes and Risk of Falls: A Systematic Review
03:00 PM - 07:30 PM	Abstract	090 - Incidence of Central Nervous System Tumors in Two Different Populations from Argentina
03:00 PM - 07:30 PM	Abstract	091 - Pattern of Pediatric Brain Tumors in Province of Egypt, a Multidisciplinary Team Experience
03:00 PM - 07:30 PM	Abstract	092 - Hemangiopericytoma Affecting the Central Nervous System
03:00 PM - 07:30 PM	Abstract	093 - Esthesioneuroblastoma: Clinical and Survival Analysis at a Single Institution in Argentina
03:00 PM - 07:30 PM	Abstract	094 - Glioblastoma Multiforme, Adenoid-Type with Melanocytic Differentiation
03:00 PM - 07:30 PM	Abstract	095 - Brain Metastases from Melanoma: Implications for Future Studies
03:00 PM - 07:30 PM	Abstract	096 - A Retrospective Study of Central Nervous System Metastases in Esophageal Cancer
03:00 PM - 07:30 PM	Abstract	097 - Incidence of Cerebral Metastasis: A Population Based Study in an Island Community
03:00 PM - 07:30 PM	Abstract	098 - Upfront Association of Carboplatin and Pemetrexed in Patients with Brain Metastasis of a Non Small Cell Lung Cancer
03:00 PM - 07:30 PM	Abstract	099 - Bevacizumab as Treatment for Brain Metastasis of Lung Cancer
03:00 PM - 07:30 PM	Abstract	100 - Leptomeningeal Plasmacytosis as an Early Manifestation of Waldenstrom's Macroglobulinemia - A Case Report
03:00 PM - 07:30 PM	Abstract	101 - Richter's Syndrome of the Spinal Cord
03:00 PM - 07:30 PM	Abstract	102 - Cranial Nerve Neuropathy as Initial Presentation of Recurrent Multiple Myeloma
03:00 PM - 07:30 PM	Abstract	103 - A Unique Case of Hyperviscosity Syndrome in a Patient with Chronic Lymphocytic Leukemia Treated with Rituximab
03:00 PM - 07:30 PM	Abstract	104 - Acute Obstructive Hydrocephallus in Griscelli Syndrome
03:00 PM - 07:30 PM	Abstract	105 - A Case of Intracranial Plasma Cell Granuloma Presenting as a Mass Lesion
03:00 PM - 07:30 PM	Abstract	106 - Subdural Hematoma in Cancer Patients
03:00 PM - 07:30 PM	Abstract	107 - Orofacial Dyskinesia: A Possible Paraneoplasic Disoder?
03:00 PM - 07:30 PM	Abstract	108 - Previous Biopsy History and Histopathological Outcome Affect Cognition and Quality of Life Following Breast Biopsy
03:00 PM - 07:30 PM	Abstract	109 - Coagulation State and Carotid Profile Assessment as a Cerebrovascular Complication in Central Nervous System Tumor
03:00 PM - 07:30 PM	Abstract	110 - Gemcitabine Induced Myopathy
03:00 PM - 07:30 PM	Abstract	111 - Voltage Gated Potassium Channel Antibody Negative Neuromyotonia and Optic Neuritis Associated with Hodgkin Lymphoma: Paraneoplastic Neuromyotonia Plus
03:00 PM - 07:30 PM	Abstract	112 - A Case of Mistaken Identity: Anti-NMDA Receptor Encephalitis in a Young Woman
03:00 PM - 07:30 PM	Abstract	113 - Steroid Responsive Encephalopathy Associated with Vestibular Symptoms and Sleep Disorders: Clinical, PSG, MSLT, ENG, CSF, and Brain MRI Correlates
03:00 PM - 07:30 PM	Abstract	114 - Brain and Spinal Cord Infarction Secondary to Giant Cell Arteritis (GCA) after Intrathecal Ziconotide
03:00 PM - 07:30 PM	Abstract	115 - Rare Neurological Complications Associated with Intravenous Immunoglobulin Infusion
03:00 PM - 07:30 PM	Abstract	116 - Striational Antibodies in a Paraneoplastic Context: A Case-Control Study
03:00 PM - 07:30 PM	Abstract	117 - Cerebrotendinous Xanthomatosis: Clinical Manifestations in Long-Term Follow-Up
03:00 PM - 07:30 PM	Abstract	118 - Cognitive Impairment in Moderate Chronic Kidney Disease Compared with Hemodialysis Patients: A Pilot Study
03:00 PM - 07:30 PM	Abstract	119 - Summary of Cardiac Safety from a Randomized, Placebo-Controlled, Trial of Dextromethorphan/Quinidine (STAR) for Treatment of Pseudobulbar Affect
03:00 PM - 07:30 PM	Abstract	120 - Cognitive Dysfunctions in Primary Sj[ouml]gren Syndrome
03:00 PM - 07:30 PM	Abstract	121 - Auto-Immune Encephalitis: Cinical, Radiological and Immunological Data
03:00 PM - 07:30 PM	Abstract	122 - Peripheral and Central Nervous System (PNS and CNS) Involvement in the Primary Carnitine Deficiency of Adult
03:00 PM - 07:30 PM	Abstract	123 - Celiac Disease Presenting as a Disabling Myopathy without Gastronintenstinal Symptoms
03:00 PM - 07:30 PM	Abstract	124 - Idiopathic Intracranial Hypertension Treatment Trial
03:00 PM - 07:30 PM	Abstract	125 - Auto-Immune Encephalitis and Striatal Hypermetabolism
03:00 PM - 07:30 PM	Abstract	126 - Hashimoto's Encephalopathy and Idiopathic Thrombocytopenic Purpura
03:00 PM - 07:30 PM	Abstract	127 - Mononeuritis Multiplex as Result of Acute Hepatitis B-Related Vasculitis
03:00 PM - 07:30 PM	Abstract	128 - Safety and Tolerability of Dextromethorphan/Quinidine for Pseudobulbar Affect in a 12-Week, Open-Label Extension Study
03:00 PM - 07:30 PM	Abstract	129 - Proton Magnetic Resonance Spectroscopy (1)H-MRS as a Tool in Neuroimmunological Disease Monitoring
03:00 PM - 07:30 PM	Abstract	130 - Hypoglycemic Encephalopathy with Normal Brain MRI
03:00 PM - 07:30 PM	Abstract	131 - Efficacy and Safety of Weekly Intramuscular Interferon Beta-1a in Patients More Than 50 Years of Age
03:00 PM - 07:30 PM	Abstract	132 - Nocebo Responses in Disease-Modifying and Symptomatic Treatment Trials for Multiple Sclerosis: A Systematic Review
03:00 PM - 07:30 PM	Abstract	133 - Natalizumab Is Effective in RRMS Patients Who Do Not Respond to Sequential Therapy with Interferon beta and Glatiramer Acetate: Result of a Switching Study
03:00 PM - 07:30 PM	Abstract	134 - Phase II Double-Blind Controlled Clinical Trial with T-Cell Vaccination in Multiple Sclerosis
03:00 PM - 07:30 PM	Abstract	135 - Cancer Risk among Patients with Multiple Sclerosis during the Treatment Era: The CARIMS Study Update
03:00 PM - 07:30 PM	Abstract	136 - Response to Treatment with Sustained Release Fampridine in Patients with Multiple Sclerosis Is Independent of Baseline Patient Characteristics and Concomitant Immunomodulator Therapy
03:00 PM - 07:30 PM	Abstract	137 - Oral Fingolimod (FTY720) Treatment Improves the Performance of Daily Activities Compared with Intramuscular Interferon [beta]-1a: Patient-Reported Indices for Multiple Sclerosis (PRIMUS)-Activities Results from a Phase III Study (TRANSFORMS)
03:00 PM - 07:30 PM	Abstract	138 - Short-Term Immunosuppression with Mitoxantrone Followed by Long-Term Glatiramer Acetate vs Glatiramer Acetate Alone: Results at 60 Months in Patients with Relapsing Multiple Sclerosis
03:00 PM - 07:30 PM	Abstract	139 - Surgical Procedures for Medically Intractable Multiple Sclerosis Associated Trigeminal Neuralgia
03:00 PM - 07:30 PM	Abstract	141 - Immunogenicity of PEGylated Interferon Beta-1a: Data from Preclinical and Phase 1 Clinical Studies
03:00 PM - 07:30 PM	Abstract	142 - Evaluation of Natalizumab for the Relief of Multiple Sclerosis Associated Fatigue: The ENER-G Study
03:00 PM - 07:30 PM	Abstract	143 - Immunotherapy after Discontinuation of Natalizumab in Relapsing Multiple Sclerosis
03:00 PM - 07:30 PM	Abstract	144 - Combined Transcranial and Extracranial Venous Doppler Evaluation (CTEVD Study). Description of the Design and Interim Results of an Epidemiological Study of the Prevalence of Chronic Cerebrospinal Venous Insufficiency in MS and Related Diseases
03:00 PM - 07:30 PM	Abstract	145 - Adherence to Disease-Modifying Therapies in Patients with Relapsing Multiple Sclerosis: 2-Year Interim Results of the Global Adherence Project
03:00 PM - 07:30 PM	Abstract	146 - Utilization and Safety of Intramuscular Interferon Beta-1a in the Postmarketing Setting
03:00 PM - 07:30 PM	Abstract	148 - Objective and Subjective Efficacy of Natalizumab on Disability and Fatigue in Relapsing Remitting (RR) and Relapsing Progressive (RP) Multiple Sclerosis (MS) over a 2 Year Period
03:00 PM - 07:30 PM	Abstract	149 - Baseline Characteristics of Patients in the DEFINE Trial: A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Randomized, Phase 3 Study of BG-12 in Relapsing-Remitting Multiple Sclerosis
03:00 PM - 07:30 PM	Abstract	150 - ReaLiNat Study: A European Multicenter Study Investigating Benefits and Risks of Natalizumab in Real Life
03:00 PM - 07:30 PM	Abstract	151 - Discontinuing Disease Modifying Therapy in Progressive Multiple Sclerosis - Can We Stop What We Have Started?
03:00 PM - 07:30 PM	Abstract	152 - Comparison of Adherence and Persistence Associated with First-Line Disease-Modifying Therapies among Patients with Multiple Sclerosis
03:00 PM - 07:30 PM	Abstract	153 - Factors Related to Adherence in Spanish Patients with MS: 2 Year Results of the GAP Study
03:00 PM - 07:30 PM	Abstract	154 - Baseline Characteristics of a Subpopulation of Indian Patients Enrolled in Two Phase 3 Trials for Oral BG-12 in Relapsing-Remitting Multiple Sclerosis
03:00 PM - 07:30 PM	Abstract	155 - Clinical Efficacy of Natalizumab and Immunological Effects in Progressive MS Patients with High Degrees of Disability
03:00 PM - 07:30 PM	Abstract	156 - Real-World Assessment of Adherence and Persistence to Second-Line Disease-Modifying Therapies among Multiple Sclerosis Patients
03:00 PM - 07:30 PM	Abstract	157 - GERONIMUS Study: Progression Rates to Multiple Sclerosis According to McDonald and Poser Criteria in Patients with Clinically Isolated Syndrome. On Behalf of the GERONIMUS Study Group
03:00 PM - 07:30 PM	Abstract	158 - Baseline Characteristics of Patients Enrolled in a Randomized, Multicenter, Placebo-Controlled and Active Comparator Trial Evaluating Efficacy and Safety of BG-12 in Relapsing-Remitting Multiple Sclerosis: The CONFIRM Trial
03:00 PM - 07:30 PM	Abstract	159 - Efficacy of Short Courses of Parenteral Cladribine in Patients with Aggressive Multiple Sclerosis
03:00 PM - 07:30 PM	Abstract	160 - High Dose Cyclophosphamide Treatment in Marburg Variant of Multiple Sclerosis (MS): A Case Report
03:00 PM - 07:30 PM	Abstract	161 - Impact of Intramuscular Interferon Beta-1a on Multiple Sclerosis Disease Severity: Analysis of Patients from the MSCRG and ASSURANCE Studies Using the Multiple Sclerosis Severity Scale
03:00 PM - 07:30 PM	Abstract	162 - Characteristics of Switching from Interferon beta to Glatiramer Acetate in Non Respondent Relapsing Remitting Multiple Sclerosis
03:00 PM - 07:30 PM	Abstract	163 - Four Cases of Co-Morbid Multiple Sclerosis and Psoriasis: Sustained Remission of Both Conditions While on Natalizumab
03:00 PM - 07:30 PM	Abstract	164 - Exploring Alemtuzumab's Long Term Efficacy and Safety: Design of the CARE-MS Extension Study
03:00 PM - 07:30 PM	Abstract	165 - Efficacy of Natalizumab in a French Cohort of Multiple Sclerosis Patients
03:00 PM - 07:30 PM	Abstract	166 - Central Demyelination Complicating the Use of Anti-TNF[alpha] in the Treatment of Inflammatory Bowel Disease(IBD): A Retrospective Study
03:00 PM - 07:30 PM	Abstract	167 - Improvement in Patient-Reported Fatigue and Cognitive Function over Time with Natalizumab Treatment
03:00 PM - 07:30 PM	Abstract	168 - Motherhood and Natalizumab - Effects of Natalizumab Therapy on Pregnancy Outcome and Disease Activity during Pregnancy
03:00 PM - 07:30 PM	Abstract	169 - Dosing of Rituximab in Demyelinating Disease: How Much Is Enough?
03:00 PM - 07:30 PM	Abstract	170 - Oral Fingolimod (FTY720) Reduces the Rate of Relapses That Require Steroid Intervention or Hospitalization Compared with Intramuscular Interferon [beta]-1a: Results from a Phase III Study (TRANSFORMS) in Multiple Sclerosis
03:00 PM - 07:30 PM	Abstract	171 - Oral Fingolimod (FTY720) vs Placebo in Relapsing-Remitting Multiple Sclerosis: 24-Month Safety and Tolerability Results from a Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase III Study (FREEDOMS)
03:00 PM - 07:30 PM	Abstract	172 - Leukocyte Dynamics Following Alemtuzumab Treatment of Relapsing-Remitting Multiple Sclerosis in a Phase 2 Study (CAMMS223)
03:00 PM - 07:30 PM	Abstract	173 - Efficacy and Safety of Natalizumab in the STRATA Study
03:00 PM - 07:30 PM	Abstract	174 - Simvastatin Treatment Favours the Long Term Outcome of Patients with ON
03:00 PM - 07:30 PM	Abstract	175 - Efficacy of Natalizumab after Insufficient Response to Other Disease Modifying Therapies for the Treatment of Relapsing Remitting Multiple Sclerosis
03:00 PM - 07:30 PM	Abstract	176 - Natalizumab Treatment for Multiple Sclerosis in Clinical Practice
03:00 PM - 07:30 PM	Abstract	178 - Immunological Response to Glatiramer Acetate in MS Patients after Different Pretreatments - The CopImmunoNet Study
03:00 PM - 07:30 PM	Abstract	179 - Development and First Evaluation of the New Patient Management and Documentation System MSDS 3D for Patients with Multiple Sclerosis
03:00 PM - 07:30 PM	Abstract	180 - Intellectual Enrichment Lessens the Negative Impact of Brain Atrophy on Cognition in Multiple Sclerosis
03:00 PM - 07:30 PM	Abstract	181 - Multiple Sclerosis (MS) and Pregnancy: A Comparison Study
03:00 PM - 07:30 PM	Abstract	182 - Inflammatory Cytokines and Chemokines in the Cerebrospinal Fluid of Multiple Sclerosis Patients Following Administration of Natalizumab
03:00 PM - 07:30 PM	Abstract	183 - PI3K[gamma]: A Sex-Specific and Novel Therapeutic Target in the Treatment of CNS Autoimmune Injury
03:00 PM - 07:30 PM	Abstract	184 - Anti-Inflammatory and Pro-Metabolic Effects of BG-12 in Glial Cells
03:00 PM - 07:30 PM	Abstract	185 - On Prediction Power of MRI for Future Development of Relapse Remitting Form of Multiple Sclerosis
03:00 PM - 07:30 PM	Abstract	186 - Relapsing Tumefactive Lesions Are Associated with a More Aggressive Course of Multiple Sclerosis
03:00 PM - 07:30 PM	Abstract	187 - Diffusion Tensor Imaging as a Clinical Trial Outcome Metric: Sample Size Estimates
03:00 PM - 07:30 PM	Abstract	188 - Memory Impairment in MS Correlates to Hemodynamic Response in Event-Related fMRI of Episodic Memory
03:00 PM - 07:30 PM	Abstract	189 - Early MS Activity on Subtraction MRI Predicts Lesion Accrual and Atrophy over 5 Years
03:00 PM - 07:30 PM	Abstract	190 - Diffusion Tensor Imaging Reveals Differences in Normal Appearing Corpus Callosum in Childhood Onset Multiple Sclerosis and Monophasic Demyelinating Events
03:00 PM - 07:30 PM	Abstract	191 - White Holes and Their Impact on Physical Disability in Patients with Multiple Sclerosis
03:00 PM - 07:30 PM	Abstract	192 - MRI-Only Conversion to MS Following a Clinically Isolated Syndrome
03:00 PM - 07:30 PM	Abstract	193 - Post-Natalizumab Rebound: A CNS Immune Reconstitution Inflammatory Syndrome (CIRIS)
03:00 PM - 07:30 PM	Abstract	194 - Diagnosing Multiple Sclerosis from Conventional MR Images Using Pattern Recognition Techniques
03:00 PM - 07:30 PM	Abstract	195 - Multiple Sclerosis and Systemic Sarcoidosis: A Double Diagnosis
03:00 PM - 07:30 PM	Abstract	196 - Cerbral Amyloid Angiitis: Two Unique Case Presentations
03:00 PM - 07:30 PM	Abstract	197 - An Unusual Case of a Rapidly Progressive Leucoencephalopathy
03:00 PM - 07:30 PM	Abstract	198 - Development of Neurosarcoidosis during Exposure to Anti-TNF-Alpha Medications for Rheumatoid Arthritis: Case Report
03:00 PM - 07:30 PM	Abstract	199 - Solitary Focal Demyelinating Lesion as a Cause of Progressive Myelopathy
03:00 PM - 07:30 PM	Abstract	200 - Multiple Sclerosis in a Patient with Duchenne Muscular Dystrophy
03:00 PM - 07:30 PM	Abstract	201 - Atypical Symptoms to 'Flag' Non-Demyelinating Disease in Patients with Suspected MS
03:00 PM - 07:30 PM	Abstract	202 - Association of Parkinsonian Syndrom with Multiple Sclerosis: A Report of 27 Cases
03:00 PM - 07:30 PM	Abstract	203 - Long-Term Intrathecal Baclofen Therapy in Ambulatory Multiple Sclerosis Patients
03:00 PM - 07:30 PM	Abstract	204 - Therapeutic Considerations and Outcome of Steroid Refractory Neurosarcoidosis: 5-Years Single Centre Experience
03:00 PM - 07:30 PM	Abstract	205 - Ingested (Oral) Somatostatin (SST) Inhibits Acute EAE
03:00 PM - 07:30 PM	Abstract	206 - Possible Neuroprotection and Th17 Modulation by a Red Wine Component, Resveratrol, in a Mouse Model for Multiple Sclerosis, Theiler's Virus Infection
03:00 PM - 07:30 PM	Abstract	207 - Detailed Analysis of CD52 Expression and Cellular Depletion/Repopulation after Alemtuzumab Treatment in HuCD52 Transgenic Mice
03:00 PM - 07:30 PM	Abstract	208 - Axonal Protection Effect of Laquinimod Appears Partially Independent of Its Inhibitory Effect on Inflammation and Demyelination in Experimental Autoimmune Encephalomyelitis
03:00 PM - 07:30 PM	Abstract	209 - Protection from CD8+ T Cell-Mediated Experimental Autoimmune Encephalomyelitis by CD28 Superagonist- or Glatiramer Acetate-Stimulated CD4+ T Cells
03:00 PM - 07:30 PM	Abstract	210 - Intrathecal Methotrexate Reduces Astrogliosis in a Murine Model of Experimental Demyelination
03:00 PM - 07:30 PM	Abstract	211 - Effects of Acamprosate (Acamp) in Experimental Autoimmune Encephalomyelitis (EAE)
03:00 PM - 07:30 PM	Abstract	212 - Oral Treatment with Purified Polysaccharide A (PSA) of Human Commensal Bacteroides fragilis Protects Against Experimental CNS Demyelinating Disease
03:00 PM - 07:30 PM	Abstract	213 - Therapeutic Effects of Oral Fingolimod (FTY720) in an Animal Model of the Progressive Disability of Multiple Sclerosis
03:00 PM - 07:30 PM	Abstract	214 - Effects of Glatiramer Acetate on T Cells in the Mouse Model
03:00 PM - 07:30 PM	Abstract	215 - Beneficial Effect of IgG Glycans Hydrolysis by EndoS in Experimental Autoimmune Encephalitis
03:00 PM - 07:30 PM	Abstract	216 - Alteration of Osteopontin Cytokine Expression in Experimental Autoimmune Encephalomyelitis by Glatiramer Acetate
03:00 PM - 07:30 PM	Abstract	217 - Lipoic Acid Confers Neuroprotection in Experimental Autoimmune Optic Neuritis
03:00 PM - 07:30 PM	Abstract	218 - A Cyclophilin D Inhibitor (Debio 025) Protects Axons in Experimental Autoimmune Encephlomyelitis: A New Therapeutic Target for Neuroprotecion in Multiple Sclerosis
03:00 PM - 07:30 PM	Abstract	219 - Dietary Supplementation with N-3 Polyunsaturated Fatty Acids Restores Normal Emotional Behaviors in Autoimmune-Prone BAFF Transgenic Mice
03:00 PM - 07:30 PM	Abstract	220 - BAF312, a Potent and Selective S1P1/5 Receptor Modulator Reverses Ongoing Chronic EAE in Mice
03:00 PM - 07:30 PM	Abstract	221 - In Vivo Characterization of the Therapeutic Effect of Glatiramer Acetate in Experimental Autoimmune Encephalomyelitis by Magnetic Resonance Imaging (MRI)
03:00 PM - 07:30 PM	Abstract	222 - Mouse Loci Influencing Inflammatory Demyelinating Disease: Shared Synteny between Tmevd2/Eae3 and the MS Locus on Chr 1 Identified by Admixture Mapping
03:00 PM - 07:30 PM	Abstract	223 - Sustained Release Fampridine Improves Walking Speed across a Wide Range of Baseline Deficits: Pooled Data from Three Placebo-Controlled Studies in Patients with Multiple Sclerosis
03:00 PM - 07:30 PM	Abstract	224 - Does Benign Form of Neuromyelitis Optica Exist?
03:00 PM - 07:30 PM	Abstract	225 - Identifying Factors That Determine Disease Susceptibility in C57BL/6 Mice for Adoptive Transfer of Experimental Autoimmune Encephalomyelitis
03:00 PM - 07:30 PM	Abstract	226 - Central Motor Conduction Failure Examined with the Triple Stimulation Technique Correlates with Pyramidal Tract Dysfunction and Disability in Patients with Multiple Sclerosis
03:00 PM - 07:30 PM	Abstract	227 - CMV Infection Modulates the Disease Course of TMEV Induced Demyelinating Disease in SJL/J Mice
03:00 PM - 07:30 PM	Abstract	228 - Cytochrome C Deficiency Ameliorates Neurodegeneration in Animal Models of Amyotrophic Lateral Sclerosis and Multiple Sclerosis
03:00 PM - 07:30 PM	Abstract	229 - Serum Phosphorylated Neurofilament Heavy Chain Is a Marker of Axonal Loss in Experimental Optic Neuritis
03:00 PM - 07:30 PM	Abstract	230 - Mercury Increases Th17 Polarization and Exacerbates Experimental Autoimmune Encephalomyelitis: Dependence on Matrix Metalloproteinase-9
03:00 PM - 07:30 PM	Abstract	231 - Etiology of Exaggerated Axon Loss in MAGKO Mice with EAE: Activated Microglia Laying in Wait?
03:00 PM - 07:30 PM	Abstract	232 - Specific Regulation of CD4 T Cells during Autoimmune Demyelination by microRNA
03:00 PM - 07:30 PM	Abstract	233 - Estrogen Dependent Attenuation of EAE in a Transgenic Mouse Expressing the RNA Regulator, HuR, in Astrocytes
03:00 PM - 07:30 PM	Abstract	235 - Relationship between Microstructural Degeneration of the Corpus Callosum, White Matter Hyperintensities, and Executive Function in Cognitively Intact Elderly
03:00 PM - 07:30 PM	Abstract	236 - Aging and Gender Effects on the Cortical Anatomical Network Efficiency
03:00 PM - 07:30 PM	Abstract	237 - Distinct White Matter Tract Changes in Frontotemporal Dementia Associated with FTLD and Alzheimer's Disease Pathology or CSF Biomarkers
03:00 PM - 07:30 PM	Abstract	238 - Structural Correlates of Memory Performance with Diffusion Tensor Imaging
03:00 PM - 07:30 PM	Abstract	239 - The Effect of Memantine on the Activity of the Resting Working Memory Network in Alzheimer's Disease
03:00 PM - 07:30 PM	Abstract	240 - Age Effect on Functional Connectivity
03:00 PM - 07:30 PM	Abstract	241 - White Matter Integrity Accounts for Reaction Time in Older Adults
03:00 PM - 07:30 PM	Abstract	242 - Early and Late Onset Alzheimer's Disease Patients Have Distinct Patterns of White Matter Damage
03:00 PM - 07:30 PM	Abstract	243 - Evidence for Brain White Matter Damage and Atrophy with Aging: A Diffusion Tensor MRI Tractography Study
03:00 PM - 07:30 PM	Abstract	244 - Regional Relation of Gray Matter Atrophy with Corpus Callosum Alteration in Normal, MCI, and AD
03:00 PM - 07:30 PM	Abstract	245 - Telcagepant Does Not Reduce Exercise Tolerance in Patients with Exercise Induced Myocardial Ischemia
03:00 PM - 07:30 PM	Abstract	246 - Cutaneous Allodynia as a Prognostic Factor in the Treatment of Migraine with Botulinum Toxin
03:00 PM - 07:30 PM	Abstract	247 - Does Gender Affect Efficacy and Tolerability of SumaRT/Nap during the Early Intervention Treatment of Migraine?
03:00 PM - 07:30 PM	Abstract	248 - Headache Prophylaxis Using Combination Therapy - A Statistical Modeling Study
03:00 PM - 07:30 PM	Abstract	249 - Experience with Botulinum Toxin Type A in the Treatment of Medically Intractable Pediatric Chronic Daily Headache
03:00 PM - 07:30 PM	Abstract	250 - OnabotulinumtoxinA for Treatment of Chronic Migraine: Analysis of the 56-Week PREEMPT 1 Trial
03:00 PM - 07:30 PM	Abstract	251 - OnabotulinumtoxinA for Treatment of Chronic Migraine: Analysis of the 56-Week PREEMPT 2 Trial
03:00 PM - 07:30 PM	Abstract	253 - OnabotulinumtoxinA for Chronic Migraine: PREEMPT Trials Establish a Safe and Effective Dose and Injection Paradigm
03:00 PM - 07:30 PM	Abstract	254 - Antialgic Effect of Low Intensity Laser in the Treatment of Cervicogenic Headaches
03:00 PM - 07:30 PM	Abstract	255 - Acute Medication Use Patterns in Episodic Migraine: Results of the American Migraine Prevalence and Prevention Study (AMPP)
03:00 PM - 07:30 PM	Abstract	256 - Spreading Depression: The Effects of Antiepileptic Drugs Used in Migraine Prophylaxis
03:00 PM - 07:30 PM	Abstract	257 - Is Telcagepant Effective in Migraineurs Who Previously Used Opioids?
03:00 PM - 07:30 PM	Abstract	258 - Fungal Sinusitis: A Surgically Treatable Cause of Chronic Daily Headache
03:00 PM - 07:30 PM	Abstract	259 - Efficacy of Enalapril in Migraine Prophylaxis: Does It Work through Endothelial Dysfunction Recovery?
03:00 PM - 07:30 PM	Abstract	260 - Intravenous Valproate Sodium Aborts Migraine Headaches Rapidly
03:00 PM - 07:30 PM	Abstract	261 - Acute Anti-Migraine Efficacy and Tolerability of Zelrix[trade], a Novel Iontophoretic Transdermal Patch of Sumatriptan
03:00 PM - 07:30 PM	Abstract	262 - Bilateral Masseter and Temporalis Hypertrophy: Case Report and Review of Literature
03:00 PM - 07:30 PM	Abstract	263 - Pulse IV Steroid and IV Valproate Combination Therapy for Sustained Relief of Chronic, Treatment Refractory Headaches in Patients with Psychiatric Disorders
03:00 PM - 07:30 PM	Abstract	264 - Regression of Chronic Migraine and High Frequency Episodic Migraine to Low Frequency Migraine through Surgery
03:00 PM - 07:30 PM	Abstract	265 - Spontaneous Retinal Venous Pulsations as a Window to CSF Pressures - Are They Reliable?
03:00 PM - 07:30 PM	Abstract	266 - A Case of Multiple Cranial Neuropathies from Perineural Spread of a Non-Melanoma Skin Cancer
03:00 PM - 07:30 PM	Abstract	267 - Serial Polysomnography in Hypnic Headache Shows No Association with REM Sleep
03:00 PM - 07:30 PM	Abstract	268 - Reversible Cerebral Vasoconstriction (RCVS) in Children and Adolescents (C/A): Its Role in Thunderclap Headaches
03:00 PM - 07:30 PM	Abstract	269 - Osmophobia Is Increased in Menstrually Associated Migraine
03:00 PM - 07:30 PM	Abstract	270 - Cardiac Autonomic Dysfunctions in Migraine Attack
03:00 PM - 07:30 PM	Abstract	271 - A Tale of Two Systems: Cardiac Cephalalgia vs. Neurologic Cardiodynia
03:00 PM - 07:30 PM	Abstract	272 - Onset and Potential Initiating Factors in New Daily-Persistent Headache
03:00 PM - 07:30 PM	Abstract	273 - Relationship between Headache Frequency and Migraine-Related Disability in the International Burden of Migraine Study (IBMS)
03:00 PM - 07:30 PM	Abstract	274 - The Effect of Serum Glucose Level on Cerebrovascular Reactivity to CO2 in Women with Migraine without Aura: Transcranial Doppler Study Using Breath Holding Method
03:00 PM - 07:30 PM	Abstract	275 - Impact of Nutritional Factors on the Prevalence of Headache or Migraine
03:00 PM - 07:30 PM	Abstract	276 - Rates and Predictors of Remission from Chronic Migraine (CM) to Episodic Migraine (EM): Results from the American Migraine Prevalence and Prevention (AMPP) Study
03:00 PM - 07:30 PM	Abstract	277 - Prevalence of Chronic Daily Headaches as a Function of Parental Headache Status - Results from the Attention Brazil Project
03:00 PM - 07:30 PM	Abstract	278 - PTSD, Drug Abuse, and Migraine: New Findings from the National Comorbidity Survey Replication (NCS-R)
03:00 PM - 07:30 PM	Abstract	279 - Cutaneous Allodynia - A Predictor of Migraine Chronification: A Longitudinal Population-Based Study
03:00 PM - 07:30 PM	Abstract	280 - Results from an International Observational Study of Pregnancy Outcomes Following Exposure to Sumatriptan, Naratriptan or the Fixed Dose Tablet Sumatriptan and Naproxen Sodium (SumaRT/Nap)
03:00 PM - 07:30 PM	Abstract	281 - Natural History of Post Traumatic Headache: Prevalence, Impact, and Clinical Characteristics
03:00 PM - 07:30 PM	Abstract	282 - An Analysis of Practice Guidelines on Headache Published by �鶹��ýӳ��
03:00 PM - 07:30 PM	Abstract	283 - New Daily Persistent Headaches (NDPH) - Follow Up and Outcome in Children and Adolescents (C/A)
03:00 PM - 07:30 PM	Abstract	284 - Body Mass Index (BMI) and Migraine in the Korean Population
03:00 PM - 07:30 PM	Abstract	285 - Temporomandibular Disorders, Headache Status and Headache Frequency: A Population-Based Study
03:00 PM - 07:30 PM	Abstract	286 - Sex Hormone Receptor Gene Polymorphisms and Migraine: A Systematic Review and Meta-Analysis
03:00 PM - 07:30 PM	Abstract	287 - Relationship between Migraine Status and Functional Outcome from Stroke
03:00 PM - 07:30 PM	Abstract	288 - Acute Treatment of Migraine in Patients with Cardiovascular Disease or Risk Factors
03:00 PM - 07:30 PM	Abstract	289 - 5-HTTLPR Polymorphism in the Serotonin Transporter Gene and Migraine: A Systematic Review and Meta-Analysis
03:00 PM - 07:30 PM	Abstract	290 - Caffeine Intake in Adolescents upon First Visit to Headache Specialty Center
03:00 PM - 07:30 PM	Abstract	291 - Association between Socioeconomic Status and Migraine with and without Aura
03:00 PM - 07:30 PM	Abstract	292 - Field Testing Chronic Migraine Criteria in the Population: Results of the German Headache Consortium (GHC) Study
03:00 PM - 07:30 PM	Abstract	293 - Triptan Use as a Function of Cardiovascular Risk. A Population-Based Study
03:00 PM - 07:30 PM	Abstract	294 - Prenatal Tabagism and Alcohol Intake Are Associated with Chronic Daily Headache at Childhood. A Population-Based Study

Faculty Disclosures
Sheena K. Aurora, MD	Dr. Aurora has received personal compensation for serving as an employee of Alzheimer's Association.
Robert D. Brown, Jr., MD, MPH, F�鶹��ýӳ��	Dr. Brown has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Craig H Neilsen Foundation. The institution of Dr. Brown has received research support from National Institutes of Health/NINDS. Dr. Brown has received publishing royalties from a publication relating to health care.
Jeffrey L. Cummings, MD, F�鶹��ýӳ��	Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia, Actinogen, Acumen, AlphaCognition, ALZpath, Aprinoia, AriBio, Artery, Biogen, Biohaven, BioVie, BioXcel, Bristol-Myers Squib, Cassava, Cerecin, Diadem, Eisai, GAP Foundation, GemVax, Janssen, Jocasta, Karuna, Lighthouse, Lilly, Lundbeck, LSP/eqt, Mangrove Therapeutics, Merck, NervGen, New Amsterdam, Novo Nordisk, Oligomerix, ONO, Optoceutics, Otsuka, Oxford Brain Diagnostics, Prothena, ReMYND, Roche, Sage Therapeutics, Signant Health, Simcere, sinaptica, Suven, TrueBinding, Vaxxinity, and Wren pharmaceutical, assessment, and investment companies. Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia, Biogen, Genentech, Grifols, Janssen, Karuna, Otsuka, reMYND, Roche, Signant Health. Dr. Cummings has stock in Artery, Vaxxinity, Behrens, Alzheon, MedAvante-Prophase, and Acumen. Dr. Cummings has received research support from NIH. Dr. Cummings has received research support from NIGMS. Dr. Cummings has received intellectual property interests from a discovery or technology relating to health care.
Richard A. Lewis, MD, F�鶹��ýӳ��	Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CSL Behring. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Nuvig. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Dianthus. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medscape. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunovant. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioCryst. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NervoSave. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TGTX. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boehringer-Ingleheim. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intellia. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cartesian. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CME Outfitters. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PeerVision. Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Up to Date. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer Ingelheim. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Intellia. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Shernoff et al. Dr. Lewis has received publishing royalties from a publication relating to health care.
Ralf Gold, MD	Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Gold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer Vital. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharamaceuticals. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishers. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Novartis. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Biogen. The institution of Dr. Gold has received research support from Novartis. The institution of Dr. Gold has received research support from Biogen.
James J. Corbett, MD	No disclosure on file
Peter A. Calabresi, MD, F�鶹��ýӳ��	Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. An immediate family member of Dr. Calabresi has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MyMD. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Myelin Repair Foundation. The institution of Dr. Calabresi has received research support from Genentech. Dr. Calabresi has received publishing royalties from a publication relating to health care. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Grant reveiwer with Myelin Repair Foundation. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker for CME with NYAS. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Academic CME.
Jayne Ness, MD	An immediate family member of Dr. Ness has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jan One. The institution of Dr. Ness has received research support from Chugai/Roche. The institution of Dr. Ness has received research support from National Multiple Sclerosis Society. The institution of an immediate family member of Dr. Ness has received research support from NIH. An immediate family member of Dr. Ness has received publishing royalties from a publication relating to health care.
	No disclosure on file
Pratik D. Bhattacharya, MD, MPH	Dr. Bhattacharya has a non-compensated relationship as a Research Advisor with Defeat MSA Alliance 501 (c) (3) that is relevant to �鶹��ýӳ�� interests or activities.
Regine Buffels, MD	Dr. Buffels has nothing to disclose.
Olivier Bailon, MD	No disclosure on file
Andrew Solomon, MD, F�鶹��ýӳ��	Dr. Solomon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Solomon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech/Roche . Dr. Solomon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kiniksa Pharmaceuticals . Dr. Solomon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Solomon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Solomon has received research support from Bristol Meyers Squibb.
Randall Kaye, MD	No disclosure on file
Kenneth C. Gorson, MD	Dr. Gorson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. Dr. Gorson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Gorson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX. Dr. Gorson has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer.
P. James B. Dyck, MD, F�鶹��ýӳ��	Dr. Dyck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea/Ionis.
Niklas Beyersdorf, MD	No disclosure on file
Bridget T. Carey, MD	No disclosure on file
Russell L. Chin, MD	No disclosure on file
Doumos Loannis	No disclosure on file
Crystal S. Fo, MD	No disclosure on file
Wendy Golden, MD	No disclosure on file
Christophe Hotermans, MD, PhD	No disclosure on file
Lloyd H. Kasper, MD	No disclosure on file
Arnaud Lacour	No disclosure on file
Nikita Tangella	No disclosure on file
Jennifer Graves, MD, PhD	Dr. Graves has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Graves has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Graves has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MSJ. The institution of Dr. Graves has received research support from Octave. The institution of Dr. Graves has received research support from Sanofi. The institution of Dr. Graves has received research support from EMD Serono.
Randolph B. Schiffer, MD	No disclosure on file
Fred D. Lublin, MD, F�鶹��ýӳ��	Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche/Genentech. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medimmune/Viela Bio/Horizon. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Receptos/Celgene/BMS. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Labcorp. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuralight. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Entelexo. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Lublin has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Multiple entities. Dr. Lublin has stock in Avotres. Dr. Lublin has stock in Neuralight. The institution of Dr. Lublin has received research support from Brainstorm. The institution of Dr. Lublin has received research support from biogen. The institution of Dr. Lublin has received research support from NIH.
Paul W. O'Connor, MD	No disclosure on file
Anthony A. Amato, MD, F�鶹��ýӳ��	Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson & Johnson. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Caballeta. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Amato has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viridian Therapeutics. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medpace. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Amato has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for legal firms. The institution of Dr. Amato has received research support from NIH. Dr. Amato has received publishing royalties from a publication relating to health care.
Sakhina Begum-Haque, PhD	No disclosure on file
Neeraj Kumar, MD	Dr. Kumar has nothing to disclose.
Katherine Agoropoulou, PhD	No disclosure on file
Wolfgang Brueck, PhD	Dr. Brueck has nothing to disclose.
Darren P. Baker, PhD	Dr. Baker has received personal compensation for serving as an employee of Sanofi. Dr. Baker has received stock or an ownership interest from Sanofi.
Marcelo E. Bigal, MD, PhD	No disclosure on file
Thomas Brennan	No disclosure on file
Catherine Buettner, MD	No disclosure on file
Christina Caon, RN, BS	Ms. Caon has received personal compensation for serving as an employee of EMD Serono.
Catherine M. Dalton, MD	No disclosure on file
Dagny N. Holle, MD	Dr. Holle has nothing to disclose.
Alexander-Thomas Kerkau, MD	No disclosure on file
Priya Kishnani, MD	Priya Kishnani, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi/Genzyme. Priya Kishnani, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amicus Therapeutics. Priya Kishnani, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Maze Therapeutics. Priya Kishnani, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for JCR Pharmaceutical. Priya Kishnani, MD has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for Asklepios Biopharmaceutical Inc. (AskBio). Priya Kishnani, MD has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Priya Kishnani, MD has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus Therapeutics. Priya Kishnani, MD has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Baebies, Inc.. The institution of Priya Kishnani, MD has received research support from Sanofi/Genzyme. Priya Kishnani, MD has received research support from Amicus Therapeutics. Priya Kishnani, MD has received intellectual property interests from a discovery or technology relating to health care. Priya Kishnani, MD has received intellectual property interests from a discovery or technology relating to health care.
Nina Kleiner, MD	No disclosure on file
Patrick M. Grogan, MD, F�鶹��ýӳ��	No disclosure on file
Noel Carlson, PhD	The institution of Mr. Carlson has received research support from Biogen. Mr. Carlson has received personal compensation in the range of $100,000-$499,999 for serving as a Employee as a Researcher with Veteran Affairs.
Alireza Minagar, MD	No disclosure on file
Richard B. Lipton, MD, F�鶹��ýӳ��	Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clexio. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has or had stock in Biohaven.Dr. Lipton has or had stock in Manistee.Dr. Lipton has or had stock in Axon.Dr. Lipton has or had stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Edward J. Cupler, MD, F�鶹��ýӳ��	Dr. Cupler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Diana Ferraro, MD, PhD	Dr. Ferraro has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme. Dr. Ferraro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Ferraro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Ferraro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Ferraro has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Dr. Ferraro has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Binding Site. Dr. Ferraro has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Donna C. Graves, MD, F�鶹��ýӳ��	Dr. Graves has nothing to disclose.
Stephanie Hreha	No disclosure on file
Jawad F. Kirmani, MD	Dr. Kirmani has nothing to disclose.
Gudarz Davar, MD	No disclosure on file
Joao M. De Moraes, MD, PhD	No disclosure on file
Andrew D. Goodman, MD, F�鶹��ýӳ��	Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Swan Bio. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IMCYSE. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Pfizer. The institution of Dr. Goodman has received research support from Atara. The institution of Dr. Goodman has received research support from Genzyme. The institution of Dr. Goodman has received research support from EMD-Serono.
Laurie Gutmann, MD, F�鶹��ýӳ��	The institution of Dr. Gutmann has received research support from NIH. Dr. Gutmann has received publishing royalties from a publication relating to health care.
Christopher J. Klein, MD, F�鶹��ýӳ��	Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma.
Melissa M. Cortez, DO	The institution of Dr. Cortez has received research support from NIH NINDS. The institution of Dr. Cortez has received research support from Dysautonomia International. Dr. Cortez has received personal compensation in the range of $500-$4,999 for serving as a Content Expert, Reviewer, DSMB with NIH RECOVER project.
Fiona Forrestal	No disclosure on file
Barry Byrne	Barry Byrne has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Barry Byrne has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rocket Pharma. Barry Byrne has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Muscular Dystrophy Association.
Sara C. Crystal, MD	Dr. Crystal has received personal compensation for serving as an employee of Thirty Madison. Dr. Crystal has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biohaven. Dr. Crystal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan.
Pierre Duquette, MD	The institution of Dr. Duquette has received research support from Biogen and Genzyme.
Juan J. Figueroa, MD	No disclosure on file
Jane Kim, MD	No disclosure on file
Marco D'Amelio, MD	No disclosure on file
Susan E. Goelz, PhD	No disclosure on file
Margaret E. Jaynes, MD	Dr. Jaynes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus.
Alexandros C. Tselis, MD, PhD	No disclosure on file
Charles S. DeCarli, MD, F�鶹��ýӳ��	Dr. DeCarli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novo Nordisk. The institution of Dr. DeCarli has received research support from NIH.
Latisha Sharma, MD	Dr. Sharma has nothing to disclose.
Kimberly Amrami, MD	Kimberly Amrami, MD has nothing to disclose.
Michael J. Boivin	No disclosure on file
Elijah Chaila, MD	No disclosure on file
Florence Chukwuneke, RN	No disclosure on file
John DeLuca, PhD, ABPP	Dr. DeLuca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. DeLuca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. DeLuca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Celgene. Dr. DeLuca has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. DeLuca has received research support from Biogen.
Ludwig Gutmann, MD, F�鶹��ýӳ��	Dr. Gutmann has a non-compensated relationship as a senior consulting editor (Humanities) with NEUROLOGY that is relevant to �鶹��ýӳ�� interests or activities.
Elissaios Karageorgiou, MD, PhD, F�鶹��ýӳ��	Dr. Karageorgiou has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrtelle. The institution of Dr. Karageorgiou has received research support from European Union. The institution of Dr. Karageorgiou has received research support from Alzheimer's Association.
Alexander Landfield, MD	No disclosure on file
Stephen D. Forner, MD	No disclosure on file
Pamela Foulds, MD	No disclosure on file
Giuliana Galassi, MD	No disclosure on file
Kymberly Gyure, MD	No disclosure on file
Declan T. Chard	No disclosure on file
Gigi J. Ebenezer, MBBS	No disclosure on file
Adrian J. Hepner, MD	No disclosure on file
Kamran A. Ahmed	No disclosure on file
Roumen D. Balabanov, MD	Dr. Balabanov has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Balabanov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Balabanov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Balabanov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Balabanov has received research support from NextCure. The institution of Dr. Balabanov has received research support from Biogen. The institution of Dr. Balabanov has received research support from NINDS.
Emilien Delmont, MD	No disclosure on file
Claude J. Desnuelle, MD	No disclosure on file
Olaf Stuve, MD, PhD, F�鶹��ýӳ��	Dr. Stuve has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Stuve has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Stuve has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Therapeutic Advances in Neurological Diseases. Dr. Stuve has received research support from US Department of Veterans Affairs. Dr. Stuve has received research support from National Multiple Sclerosis Society (US). Dr. Stuve has received research support from Merck KGaA.
Alasdair Coles, MD, PhD	Dr. Coles has nothing to disclose.
Benjamin R. Brooks, MD, F�鶹��ýӳ��	Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medicinova. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mitsubishi Tanabe Pharma America. The institution of Dr. Brooks has received research support from Mitsubishi TanabePharma America. Dr. Brooks has received personal compensation in the range of $0-$499 for serving as a Member Annual Surveillance Committee CDC National ALS Registry with Center for Disease Control Agency Toxic Substances Disease Registry. Dr. Brooks has a non-compensated relationship as a Member ALS Quality Measures Subcommittee with �鶹��ýӳ�� that is relevant to �鶹��ýӳ�� interests or activities.
Steven Benedict, MD	Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SKLife. The institution of Dr. Benedict has received research support from Sanofi. The institution of Dr. Benedict has received research support from Novartis.
X. Henry Hu, MD, PhD	No disclosure on file
Vassiliki Kotsi	No disclosure on file
Jennifer A. Langsdorf, MD	Dr. Langsdorf has nothing to disclose.
Exuperio Diez-Tejedor, MD, PhD	No disclosure on file
M. Maria Glymour, PhD	No disclosure on file
Liat Hayardeny Nisimov, PhD	No disclosure on file
Stephanie Jurgensen, PhD	No disclosure on file
Anna Karydas	No disclosure on file
Benjamin M. Greenberg, MD, F�鶹��ýӳ��	Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Clene. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Greenberg has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Siegel Rare Neuroimmune Association. Dr. Greenberg has or had stock in GenrAb.Dr. Greenberg has or had stock in Clene.Dr. Greenberg has received intellectual property interests from a discovery or technology relating to health care. Dr. Greenberg has received publishing royalties from a publication relating to health care.
Angel Angelov, MD	No disclosure on file
Roberto Bomprezzi, MD, F�鶹��ýӳ��	Dr. Bomprezzi has nothing to disclose.
Nazely Ashikian, MD	Dr. Ashikian has nothing to disclose.
Diana Balsalobre, MD	No disclosure on file
Brendan Bauer, MD, F�鶹��ýӳ��	No disclosure on file
Nancy Chiaravalloti	The institution of Nancy Chiaravalloti has received research support from NIH. The institution of Nancy Chiaravalloti has received research support from NIDILRR.
Ruxandra M. Costa, MD	No disclosure on file
Walter F. Haupt, MD, Prof, F�鶹��ýӳ��	No disclosure on file
Gyanendra Kumar, MD, F�鶹��ýӳ��	Dr. Kumar has received personal compensation in the range of $500-$4,999 for serving as a Medical Consultant with Arizona Medical Board.
Rainer Apfel, MD	No disclosure on file
Doris Cardenas, MD	No disclosure on file
Owen T. Carmichael, PhD	No disclosure on file
Gilles Defer, MD	Dr. Defer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Defer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen . Dr. Defer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Dr. Defer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche.
Daniel R. Wynn, MD	Dr. Wynn has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mylan. Dr. Wynn has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Wynn has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Wynn has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. Dr. Wynn has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TEVA. The institution of Dr. Wynn has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Banner Life. Dr. Wynn has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Biogen. The institution of Dr. Wynn has received research support from Novartis. The institution of Dr. Wynn has received research support from Sanofi. The institution of Dr. Wynn has received research support from Adamas Pharmaceutics. The institution of Dr. Wynn has received research support from EMD Serono. The institution of Dr. Wynn has received research support from Roche. Dr. Wynn has a non-compensated relationship as a Director, Consultants in Neurology Comprehensive Care Center with National MS Society that is relevant to �鶹��ýӳ�� interests or activities.
Ignacio F. Casas-Parera, MD, PhD, F�鶹��ýӳ��	Dr. Casas-Parera has received publishing royalties from a publication relating to health care.
Keith R. Edwards, MD, F�鶹��ýӳ��	No disclosure on file
Erik P. Pioro, MD, DPhil, F�鶹��ýӳ��	Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avanir Pharmaceutical, Inc.. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx Pharmaceuticals. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MT Pharma America, Inc.. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroTherapia, Inc.. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT Pharma America, Inc..
Reto M. Agosti, MD	No disclosure on file
Andrew H. Chan, MD	No disclosure on file
Ivan Garza, MD, F�鶹��ýӳ��	No disclosure on file
Deborah I. Friedman, MD, MPH, F�鶹��ýӳ��	Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Friedman has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Pfizer. Dr. Friedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Friedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Friedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Axsone. Dr. Friedman has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Pfizer. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology . Dr. Friedman has a non-compensated relationship as a Program Co-Chair, Scottsdale Headache Symposium with American Headache Society that is relevant to �鶹��ýӳ�� interests or activities. Dr. Friedman has a non-compensated relationship as a Medical Advisor with Spinal CSF Leak Foundation that is relevant to �鶹��ýӳ�� interests or activities. Dr. Friedman has a non-compensated relationship as a President-elect, Board of Directors with Southern Headache Society that is relevant to �鶹��ýӳ�� interests or activities.
Doralina G. Brum	No disclosure on file
James Bicksel, MD	No disclosure on file
Leah Gaedeke, MSN, FNP-BC	No disclosure on file
Marek Gawel, FRCPC	No disclosure on file
Gene Y. Sung, MD, MPH	The institution of Dr. Sung has received research support from NIH.
Mark A. Ferrante, MD, F�鶹��ýӳ��	No disclosure on file
Dawn C. Buse, PhD	Dr. Buse has received personal compensation for serving as an employee of Vector Psychometric Group. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranicsa. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Buse has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Pain and Headache Reports. The institution of Dr. Buse has received research support from Amgen. The institution of Dr. Buse has received research support from FDA. The institution of Dr. Buse has received research support from National Headache Foundation.
David W. Dodick, MD, F�鶹��ýӳ��	Dr. Dodick has received personal compensation for serving as an employee of Mayo Clinic. Dr. Dodick has received personal compensation for serving as an employee of Atria Health. Dr. Dodick has received personal compensation for serving as an employee of Thomas Jefferson University . Dr. Dodick has received personal compensation for serving as an employee of Norwegian University of Science and Technology. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Allergan. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biopharm Communications. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inside Practice Australia. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical �鶹��ýӳ�� Alliance. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Headache Cooperative of the Pacific . Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medica Communications. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJ Healthcare. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nocira. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance . Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communications. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vector Psychometrics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as a Consultant for Ayya Biosciences. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as a Consultant for Theranica. Dr. Dodick has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Atria. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for WebMD. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Thomas Jefferson University. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medforce. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision HEOR. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Canadian Headache Society. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Headache Cooperative of New England. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen Japan. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for KingDevick Technologies. Dr. Dodick has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Precon Health. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Ontologics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Matterhorn. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Axon Therapeutics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Cephalgia Group. Dr. Dodick has stock in Healint. Dr. Dodick has stock in Theranica. Dr. Dodick has stock in Aural Analytics . Dr. Dodick has stock in Epien. Dr. Dodick has stock in Matterhorn. Dr. Dodick has stock in Ontologics. Dr. Dodick has stock in Precon Health. Dr. Dodick has stock in King Devick Technologies. Dr. Dodick has stock in Nocira. Dr. Dodick has stock in Exsano. Dr. Dodick has stock in Palion. Dr. Dodick has stock in AYYA Biosciences. Dr. Dodick has stock in Perfood. Dr. Dodick has stock in Cephalgia Group. Dr. Dodick has stock in Atria Health. Dr. Dodick has stock in Man and Science. Dr. Dodick has stock in Eigenlyfe. An immediate family member of Dr. Dodick has stock in ScotiaLyfe. Dr. Dodick has stock in Axon Therapeutics. The institution of Dr. Dodick has received research support from Department of Defense. The institution of Dr. Dodick has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Dodick has received research support from Henry Jackson Foundation. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has a non-compensated relationship as a Chair with American Brain Foundation that is relevant to �鶹��ýӳ�� interests or activities. Dr. Dodick has a non-compensated relationship as a Committee member/Course Director with �鶹��ýӳ�� that is relevant to �鶹��ýӳ�� interests or activities. Dr. Dodick has a non-compensated relationship as a Chair/Immediate Past Chair with American Migraine Foundation that is relevant to �鶹��ýӳ�� interests or activities. Dr. Dodick has a non-compensated relationship as a Chair Global Patient Advocacy Coalition with International Headache Society that is relevant to �鶹��ýӳ�� interests or activities.
Priya Chaudhary	No disclosure on file
Andrew M. Blumenfeld, MD, F�鶹��ýӳ��	Dr. Blumenfeld has received personal compensation for serving as an employee of The Los Angeles Headache Center. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Allergan/Abbvie. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Best Doctors. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Guidepoint. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GLG. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Theranica. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Aeon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Revance. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Lundbeck. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Axsome. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Axon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Cedar Sinai. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axsome. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Allergan/Abbvie. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Teva. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Lilly. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Lundbeck. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for AXSOME.
Stephen D. Silberstein, MD, F�鶹��ýӳ��	Dr. Silberstein has received publishing royalties from a publication relating to health care.
William R. Bauer, MD, PhD, F�鶹��ýӳ��	No disclosure on file
Rima N. El-Abassi, MD	Dr. El-Abassi has nothing to disclose.
Clementine Karageorgiou, MD	The institution of Dr. Karageorgiou has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for GENESIS PHARMA. The institution of Dr. Karageorgiou has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for TEVA-SPECIFAR.
Siobhan Kelly, MD	Dr. Kelly has nothing to disclose.
Francesca Bagnato, MD	Dr. Bagnato has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Bagnato has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyne. Dr. Bagnato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Bagnato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jenseen. Dr. Bagnato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merk-Serono.
Adrian Burgos, MD	No disclosure on file
Daniel Gendron, MD	No disclosure on file
Bruno J. Giordani, PhD	No disclosure on file
Tamara Miller, MD	Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics Therapeutics, Abbvie, Genentech. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono, TG Therapeutics, Biogen, Abbvie, Genentech, Lundbeck. The institution of Dr. Miller has received research support from Abbvie, Ipsen, Alexion, Pfizer, BMS, Genentech, ThermoFisher Scientific.
Joan M. Ohayon	Joan M. Ohayon has nothing to disclose.
Aiden Haghikia, MD	Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. The institution of Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Galapagos. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck Serono. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyverna. Dr. Haghikia has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neuraxpharm. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Biogen. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Sanofi. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Novartis. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Merck Serono. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Celgene.
Meena A. Kanikannan, MD	No disclosure on file
Jayawant N. Mandrekar, PhD	Dr. Mandrekar has nothing to disclose.
Michelle Lener, PharmD	No disclosure on file
Amy E. Lovett Racke, PhD	No disclosure on file
Jin J. Luo, MD, PhD, F�鶹��ýӳ��	Dr. Luo has nothing to disclose.
Angela L. Genge, MD	Dr. Genge has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AL-S Pharma. Dr. Genge has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. Dr. Genge has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Quralis. Dr. Genge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Genge has received personal compensation in the range of $0-$499 for serving as a Consultant for WAVE. Dr. Genge has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for eikonizo. Dr. Genge has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for rapa.
Dong Young Lee, MD, PhD	No disclosure on file
Babak Navi, MD	Dr. Navi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Navi has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MindRhythm Inc. Dr. Navi has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for multiple medicolegal firms.
Pahari Ghosh, MD, MBBS, MRCP	No disclosure on file
David T. Jones, MD	Dr. Jones has stock in Cephlodyne Neurotechnologies, Inc.. Dr. Jones has received intellectual property interests from a discovery or technology relating to health care.
Norman Latov, MD, PhD	Dr. Latov has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Polyneuron. Dr. Latov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Therapath LLC. Dr. Latov has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Mcaloon & Freeman, PC. Dr. Latov has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Conway Homer PC. Dr. Latov has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Sylvia Chin-Kaplan, LLC. The institution of Dr. Latov has received research support from Takeda. Dr. Latov has received publishing royalties from a publication relating to health care.
Mary M. Machulda, PhD	The institution of Dr. Machulda has received research support from NIH.
Sulaiman Mohammad, MD	No disclosure on file
Paolo F. Nichelli, MD	No disclosure on file
Ryan O'Donnell	No disclosure on file
Richard A. Rudick, MD, F�鶹��ýӳ��	Dr. Rudick has received personal compensation for serving as an employee of Biogen. Dr. Rudick has received stock or an ownership interest from Biogen. Dr. Rudick has received publishing royalties from a publication relating to health care.
Christopher A. Scheiner, MD, PhD	Dr. Scheiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Scheiner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals . Dr. Scheiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring . Dr. Scheiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx Pharmaceuticals. Dr. Scheiner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Scheiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Scheiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jansssen. Dr. Scheiner has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for CSL Behring . Dr. Scheiner has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals . Dr. Scheiner has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Scheiner has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. The institution of Dr. Scheiner has received research support from Alexion Pharmaceuticals .
Karl D. Kieburtz, MD	Dr. Kieburtz has received personal compensation for serving as an employee of Clintrex Research Corporation. Dr. Kieburtz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Kieburtz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Kieburtz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Kieburtz has stock in Clintrex Research Corp. Dr. Kieburtz has stock in Hoover Brown. An immediate family member of Dr. Kieburtz has stock in Hoover Brown. Dr. Kieburtz has stock in Safe Therapeutics. The institution of Dr. Kieburtz has received research support from NIH. The institution of Dr. Kieburtz has received research support from Michae J Fox Foundation.
Mark J. Kupersmith, MD, F�鶹��ýӳ��	Dr. Kupersmith has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Legal firms. Dr. Kupersmith has stock in SafeTherapeutics m,LLC. The institution of Dr. Kupersmith has received research support from NEI, NYEEI FDN, Shulman Family NAION fund. Dr. Kupersmith has received intellectual property interests from a discovery or technology relating to health care.
Michael R. Frankel, MD	The institution of Dr. Frankel has received research support from Nico Corporation, Inc.
Fredric K. Cantor, MD, F�鶹��ýӳ��	No disclosure on file
Elisabeth A. Cats, MD	No disclosure on file
David R. Cornblath, MD	Dr. Cornblath has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Octapharma. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon. Dr. Cornblath has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Cornblath has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cigna. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Anavex. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hansa. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MPTP. Dr. Cornblath has received intellectual property interests from a discovery or technology relating to health care.
Kerstin Hellwig	Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mylan . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche . The institution of Kerstin Hellwig has received research support from Roche . The institution of Kerstin Hellwig has received research support from Merck . The institution of Kerstin Hellwig has received research support from Biogen. The institution of Kerstin Hellwig has received research support from Genzyme . The institution of Kerstin Hellwig has received research support from Novartis . The institution of Kerstin Hellwig has received research support from BMS .
Shalini Mahajan, MD, F�鶹��ýӳ��	No disclosure on file
Roy H. Hamilton, MD, MS, FANA, F�鶹��ýӳ��	Dr. Hamilton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Highland Instruments. Dr. Hamilton has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognito Therapeutics. Dr. Hamilton has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for McKnight Brain Research Foundation. The institution of Dr. Hamilton has received research support from NIH. The institution of Dr. Hamilton has received research support from Department of Defense. The institution of Dr. Hamilton has received research support from Chan Zuckerberg Initiative.
Peter A. Michas-Martin, MD	No disclosure on file
Tania Giovannetti	No disclosure on file
Mark Gorman, MD	The institution of Dr. Gorman has received research support from Pfizer. The institution of Dr. Gorman has received research support from Roche / Genetech .
Bhupendra O. Khatri, MD, F�鶹��ýӳ��	Dr. Khatri has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Alexion. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Khatri has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for ER Squibb (Bristol Myer Squibb). Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizone. Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Khatri has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genzyne. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme. Dr. Khatri has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Seronoe. Dr. Khatri has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for E.R. Squibb. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Khatri has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Janssen. Dr. Khatri has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutic. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genzyme. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx US. The institution of Dr. Khatri has received research support from Biogen.
David Kline, MD	No disclosure on file
Ramesh Madhavan, MD, F�鶹��ýӳ��	Dr. Madhavan has received stock or an ownership interest from TiaTech USA and TiaTech India. Dr. Madhavan has received intellectual property interests from a discovery or technology relating to health care.
Paolo Ragonese	No disclosure on file
Hassan H. Salama, MD, PhD	No disclosure on file
Phillip A. Low, MD, F�鶹��ýӳ��	Dr. Low has nothing to disclose.
Macarena De La Fuente, MD	Dr. De La Fuente has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier Pharmaceuticals. Dr. De La Fuente has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pyramid Biosciences. An immediate family member of Dr. De La Fuente has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. An immediate family member of Dr. De La Fuente has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ADC Therapeutics.
Rania A. Elenein, MD	Dr. Elenein has nothing to disclose.
Tiara Aninditha, MD	No disclosure on file
Taylor C. Bear, MD	No disclosure on file
Esther Brusse	No disclosure on file
Stephen Gancher, MD, F�鶹��ýӳ��	No disclosure on file
Vincenzo Guidetti	No disclosure on file
Krista Kuitwaard, MD	No disclosure on file
Connie Lau, MS, CCRC	No disclosure on file
Xinrong Lu, MD, PhD	No disclosure on file
Agust Hilmarsson, MD	No disclosure on file
Tony W. Ho, MD	No disclosure on file
Vasiliki N. Ikonomidou	No disclosure on file
Michael Ko, MD	No disclosure on file
Bibhuti Mishra, MD	No disclosure on file
John W. Griffin, MD	No disclosure on file
Murray Grossman, MD, F�鶹��ýӳ��	Dr. Grossman has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Grossman has received research support from NIH.
Bruce L. Hughes, MD, F�鶹��ýӳ��	No disclosure on file
Ludwig Kappos, MD, F�鶹��ýӳ��	Dr. Kappos has nothing to disclose.
Vishal Patel, MD	No disclosure on file
Sandipan Pati, MD	Dr. Pati has nothing to disclose.
Xin Liu	No disclosure on file
Wazim Mohamed, MD	Dr. Mohamed has nothing to disclose.
J. P. Mohr, MD, F�鶹��ýӳ��	The institution of Dr. Mohr has received research support from NINDS Grant R01 NS099268 NIH-NINDS .
Christopher S. Nance, MD	No disclosure on file
Stephen M. Rao, PhD	No disclosure on file
Sonemany Salinthone, PhD	Dr. Salinthone has nothing to disclose.
Ninan T. Mathew, MD	No disclosure on file
Andre M. Mueller, PhD	No disclosure on file
Uri Napchan, MD	No disclosure on file
Barry S. Oken, MD, PhD, F�鶹��ýӳ��	Dr. Oken has nothing to disclose.
Spozhmy Panezai, MD	Dr. Panezai has nothing to disclose.
Mark W. Pierce, MD, PhD	No disclosure on file
John W. Rose, MD, F�鶹��ýӳ��	The institution of Dr. Rose has received research support from National Multiple Sclerosis Society. The institution of Dr. Rose has received research support from Guthy Jackson Charitable Foundation. The institution of Dr. Rose has received research support from NIH . The institution of Dr. Rose has received research support from VA. The institution of Dr. Rose has received research support from Biogen. The institution of Dr. Rose has received research support from Friends of MS. Dr. Rose has received intellectual property interests from a discovery or technology relating to health care.
Susan Simonyi, RN	No disclosure on file
Shrikant Mishra, MD	Dr. Mishra has nothing to disclose.
David D. Adams	David D. Adams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ALNYLAM. David D. Adams has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer.
Denise I. Campagnolo, MD, MS	Dr. Campagnolo has received personal compensation for serving as an employee of Biogen. Dr. Campagnolo has received stock or an ownership interest from Biogen.
Jae-Myun Chung, MD	No disclosure on file
Sureyya Dikmen, PhD	No disclosure on file
Kelly Donnelly, DO	No disclosure on file
Adilia M. Hormigo, MD, PhD	Dr. Hormigo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TargTex.
Kyung Mi Oh, MD	No disclosure on file
Hiroyuki Nodera, MD	No disclosure on file
Megha Shah	Megha Shah has received personal compensation for serving as an employee of AbbVie. Megha Shah has stock in AbbVIe .
Jason Silversteen, DO	Dr. Silversteen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche-Genentech. Dr. Silversteen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viela Bio. Dr. Silversteen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche-Genentech.
Christian Lampl, MD, PhD	No disclosure on file
Wolfgang Mair, MD	No disclosure on file
Sandra R. Richman, MD	No disclosure on file
Paulo Marcelo G. Sales	No disclosure on file
Meena Subramanyam, PhD	No disclosure on file
Robert Zivadinov, MD, PhD, F�鶹��ýӳ��	The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Omnicuris. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrobalan. Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Shahram Attarian, MD, PhD	Prof. Attarian has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI, Pfizer LFB, Alnylam Biogen Argenx, UCB Alexion, Astrazenica, Amicus, Janssen, Novartis, Roche. Prof. Attarian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SANOFI, Biogen,Alnylam, Argenx, USB, Alexion Astrazenica, Janssen, Roche, Amgen. The institution of Prof. Attarian has received research support from National Institut of Health .
Abdalla Bowirrat	No disclosure on file
David J. Capobianco, MD, F�鶹��ýӳ��	No disclosure on file
Suyash Prasad, MBBS	Dr. Prasad has received personal compensation for serving as an employee of Audentes Therapeutics. Dr. Prasad has received stock or an ownership interest from Audentes.
Gina Remington	No disclosure on file
Brian Scott, MD	Dr. Scott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Legend Biotech.
Michelle L. Mauermann, MD, F�鶹��ýӳ��	The institution of Dr. Mauermann has received research support from Intellia. Dr. Mauermann has received publishing royalties from a publication relating to health care.
Eva Medova	No disclosure on file
Giuseppe Salemi, MD	No disclosure on file
Kathe Dahlbom, MD	No disclosure on file
Winston R. Ortiz, MD	No disclosure on file
Ted Phillips, MD	No disclosure on file
Kartik Sivaraaman, MD	No disclosure on file
Mary Walch	No disclosure on file
Anke C. Winter, MD, MSc	No disclosure on file
Sourabh Arora	No disclosure on file
Edouard Hirsch	No disclosure on file
Byung-kun Kim, MD	Dr. Kim has nothing to disclose.
Hillel S. Panitch, MD	No disclosure on file
Randall T. Schapiro, MD, F�鶹��ýӳ��	No disclosure on file
Manuela Vaneckova	Manuela Vaneckova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Manuela Vaneckova has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Manuela Vaneckova has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Manuela Vaneckova has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Manuela Vaneckova has received research support from Czech Ministry of Health project—grants NU 22-04-00193 . Manuela Vaneckova has received research support from Czech Ministry of Health project - RVO VFN 64165 . Manuela Vaneckova has received personal compensation in the range of $500-$4,999 for serving as a principal investigator with Czech Ministry of Health project—grants NU 22-04-00193 .
David S. Saperstein, MD	No disclosure on file
Bjarne A. Udd, MD	No disclosure on file
Jeffrey A. Cohen, MD	Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Convelo. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria. Dr. Cohen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSI. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celltrion.
Claudia Castiglioni, MD	Dr. Castiglioni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Castiglioni has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for PTC.
Michael Gruenthal, MD, PhD	No disclosure on file
J. R. Singleton, MD	Dr. Singleton has received research support from NIH.
Tomislav Babic	No disclosure on file
Christopher Cunniff, MD	No disclosure on file
Rachel Halpern, PhD	No disclosure on file
Virginia Lee, PhD	Virginia Lee, PhD has nothing to disclose.
Timothy L. Vollmer, MD, F�鶹��ýӳ��	The institution of Dr. Vollmer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen IDEC. The institution of Dr. Vollmer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siranax. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Meyers Squib. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela Bios. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. The institution of Dr. Vollmer has received research support from Rocky Mountain MS Center. The institution of Dr. Vollmer has received research support from Biogen. The institution of Dr. Vollmer has received research support from Actelion. The institution of Dr. Vollmer has received research support from Genentech/Roche. The institution of Dr. Vollmer has received research support from Anokion. The institution of Dr. Vollmer has received research support from TG Therapeutics.
Fereshteh Ashtari	Fereshteh Ashtari has nothing to disclose.
Benjamin Eckert	No disclosure on file
Scott E. Kasner, MD, F�鶹��ýӳ��	Dr. Kasner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Kasner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Kasner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Javelin. Dr. Kasner has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. The institution of Dr. Kasner has received research support from WL Gore. The institution of Dr. Kasner has received research support from DiaMedica. The institution of Dr. Kasner has received research support from Bayer.
Ryan D. Walsh, MD	No disclosure on file
Frederik Barkhof, MD, PhD	Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Frederik Barkhof has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Combinostics. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IXICO. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EISAI.
Gary R. Cutter, PhD	Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for onsulting or Advisory Boards: Alexion, Antisense Therapeutics/Percheron, Avotres, Biogen, Clene Nanomedicine, Clinical Trial Solutions LLC, Endra Life Sciences, Cognito Therapeutics, Genzyme, Genentech, Immunic, Klein-Buendel Incorporated, Kyverna Therapeutics, Inc. , Linical, Merck/Serono, Noema, Neurogenesis, Perception Neurosciences, Protalix Biotherapeutics, Regeneron, Revelstone Consulting, Roche, SAB Biotherapeutics, Sapience Therapeutics, Scott&Scott LLP, Tenmile.. Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Data and Safety Monitoring Boards: Applied Therapeutics, AI therapeutics, AMO Pharma, Argenx, Astra-Zeneca, Avexis Pharmaceuticals, Bristol Meyers Squibb, CSL Behring, Cynata Therapeutics, DiamedicaTherapeutics, Horizon Pharmaceuticals, Immunic, Inhibrix, Karuna Therapeutics, Kezar Life Sciences, Medtronic, Merck, Meiji Seika Pharma, Mitsubishi Tanabe Pharma Holdings, Prothena Biosciences, Novartis, Pipeline Therapeutics (Contineum), Regeneron, Sanofi-Aventis, Teva Pharmaceuticals, United BioSource LLC, University of Texas Southwestern.. Dr. Cutter has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JASN.
Gang Zhang, MD, PhD	No disclosure on file
Mahmoud Rayes, MD	No disclosure on file
Matthew S. Robbins, MD, F�鶹��ýӳ��	Dr. Robbins has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Robbins has received publishing royalties from a publication relating to health care. Dr. Robbins has a non-compensated relationship as a Board of Directors member, �鶹��ýӳ�� Program speaker with American Headache Society that is relevant to �鶹��ýӳ�� interests or activities. Dr. Robbins has a non-compensated relationship as a Board of Directors member, �鶹��ýӳ�� Program speaker with New York State Neurological Society that is relevant to �鶹��ýӳ�� interests or activities. Dr. Robbins has a non-compensated relationship as a Editorial Board Member with Continuum, �鶹��ýӳ�� that is relevant to �鶹��ýӳ�� interests or activities.
Dessa Sadovnick, PhD	No disclosure on file
F. M. Cutrer, MD	Dr. Cutrer has received publishing royalties from a publication relating to health care.
Susan Cadell, PhD	No disclosure on file
Xi Chen, MD, PhD	No disclosure on file
Christopher Lines	No disclosure on file
Rohit A. Marawar, MD, F�鶹��ýӳ��	Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Pharma. Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon. Dr. Marawar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis.
Catalina Cleves, MD	Dr. Cleves has nothing to disclose.
Benjamin Cretin, MD	No disclosure on file
Shalaka D. Indulkar, MD	No disclosure on file
Julius Latorre, MD, F�鶹��ýӳ��	Dr. Latorre has nothing to disclose.
Saud Sadiq, BS, F�鶹��ýӳ��	Ms. Brewi has nothing to disclose.
Giovanni Savettieri, MD	No disclosure on file
Karen C. Albright, DO, DO, PhD, MS, MPH	Dr. Albright has nothing to disclose.
Rami Ausi, MD	No disclosure on file
Barbara Changizi, MD	Dr. Changizi has nothing to disclose.
Feza Deymeer, MD	No disclosure on file
Na Tosha N. Gatson, MD, PhD, F�鶹��ýӳ��	Dr. Gatson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GT Medical Technologies. Dr. Gatson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Menarini Silicon Biosystems. Dr. Gatson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NuvOx Pharmaceuticals. Dr. Gatson has received publishing royalties from a publication relating to health care. Dr. Gatson has a non-compensated relationship as a Board Member with Society for Equity in Neurosciences (SEQUINS) that is relevant to �鶹��ýӳ�� interests or activities.
Christian Grommes, MD	Dr. Grommes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono. Dr. Grommes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BTG. Dr. Grommes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Grommes has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Curis. Dr. Grommes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ono.
Mark Gudesblatt, MD	The institution of Dr. Gudesblatt has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for genentech. The institution of Dr. Gudesblatt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
H. R. Jones, Jr., MD	No disclosure on file
Thomas J. Kaley, MD	Dr. Kaley has received publishing royalties from a publication relating to health care.
Gunther Ladurner, MD	No disclosure on file
Mayowa Owolabi, MD, F�鶹��ýӳ��	Dr. Owolabi has nothing to disclose.
Helmut Rauschka, MD	No disclosure on file
Michael L. Reed, PhD	The institution of Dr. Reed has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. The institution of Dr. Reed has received research support from Allergan. The institution of Dr. Reed has received research support from Dr Reddy's Labs/Promius. The institution of Dr. Reed has received research support from Allay Lamp. Dr. Reed has a non-compensated relationship as a Research Analyst with National Headache Foundation that is relevant to �鶹��ýӳ�� interests or activities.
Adrienne Salomon, MD	No disclosure on file
Paul A. Smith	No disclosure on file
Giovanni B. Frisoni, MD	No disclosure on file
Kathleen Alwell	No disclosure on file
JaNean Engelstad	JaNean Engelstad has nothing to disclose.
Cecilia Grau Espinosa, PhD	No disclosure on file
Stanley J. Iyadurai, MD, PhD, F�鶹��ýӳ��	Dr. Iyadurai has received personal compensation for serving as an employee of Catalyst Pharmaceuticals. Dr. Iyadurai has received stock or an ownership interest from Catalyst Pharmaceuticals.
Robert Kane, PhD, ABPP-CN	No disclosure on file
Beth B. Hogans, MD, PhD	Dr. Hogans has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for American Academy of Pain Medicine. The institution of Dr. Hogans has received research support from VA Office of Research and Development. Dr. Hogans has received intellectual property interests from a discovery or technology relating to health care. Dr. Hogans has received publishing royalties from a publication relating to health care. Dr. Hogans has received publishing royalties from a publication relating to health care. Dr. Hogans has a non-compensated relationship as a Grant reviewer with Veterans Affairs Office of Research and Development that is relevant to �鶹��ýӳ�� interests or activities. Dr. Hogans has a non-compensated relationship as a Grant reviewer with National Institutes of Health that is relevant to �鶹��ýӳ�� interests or activities.
Simon Podnar, MD	No disclosure on file
Javier Ochoa-Reparaz, PhD	No disclosure on file
Gisele R. Oliveira, MD	No disclosure on file
Dominick Paes	No disclosure on file
Deborah Reed, MD	No disclosure on file
Lakshmi Shankar, MD	No disclosure on file
David J. Libon, PhD	No disclosure on file
Mark Obermann, MD, F�鶹��ýӳ��	No disclosure on file
Marc Rosenblum	No disclosure on file
Stephen L. Hauser, MD	Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NGM Bio. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BD. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pheno Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nurix Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilead. Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Accure. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hinge Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Neurona. Dr. Hauser has a non-compensated relationship as a Clinical Trial/Primary Investigator with Roche that is relevant to �鶹��ýӳ�� interests or activities. Dr. Hauser has a non-compensated relationship as a Clinical Trial/Primary Investigator with Novartis that is relevant to �鶹��ýӳ�� interests or activities.
Franz Aichner, MD	No disclosure on file
Estefania Arroyo	No disclosure on file
Richard K. Kim, MD	Dr. Kim has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for RKK Consulting, Inc..
Lenore J. Launer, PhD	No disclosure on file
Jan-Mendelt Tillema, MD	Dr. Tillema has nothing to disclose.
Mesha Gay Brown, MD	Dr. Brown has nothing to disclose.
Ron Cohen, MD	Dr. Cohen has received personal compensation for serving as an employee of Acorda Therapeutics. Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for VBL Therapeutics. Dr. Cohen has stock in Acorda Therapeutics.
Carl Dahlof	No disclosure on file
Kazim A. Sheikh, MD	The institution of Dr. Sheikh has received research support from NIH. The institution of Dr. Sheikh has received research support from DoD.
Muhammad Zaidi, MD	Dr. Zaidi has nothing to disclose.
Istvan Pirko, MD, F�鶹��ýӳ��	No disclosure on file
Saad Abu Saleh	No disclosure on file
Tania Arguello	No disclosure on file
Andrew Blight, PhD	No disclosure on file
Bruno Eymard, MD	No disclosure on file
Thomas K. Koch, MD	Dr. Koch has nothing to disclose.
Jan Krasensky, MD	No disclosure on file
Kwang-Soo Lee, MD	No disclosure on file
Lawrence Marinucci	No disclosure on file
Dominik S. Meier, PhD	No disclosure on file
Sumit Parikh, MD	Dr. Parikh has received personal compensation in the range of $0-$499 for serving as a Consultant for Epirium. The institution of Dr. Parikh has received research support from CHAMP. The institution of Dr. Parikh has received research support from Mitochondrial Medicine Society. The institution of Dr. Parikh has received research support from Minovia. The institution of Dr. Parikh has received research support from Acadia. The institution of Dr. Parikh has received research support from Stealth. Dr. Parikh has received publishing royalties from a publication relating to health care.
Claudio Semplicini	No disclosure on file
Marie Theaudin, MD	No disclosure on file
Marcin P. Mycko, MD	No disclosure on file
Michael J. Polydefkis, MD, F�鶹��ýӳ��	Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam Pharmaceuticals. Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharmaceutical . Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen-Idec. Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer.
Fumitaka Sato, PhD	No disclosure on file
Sait Ashina, MD	Dr. Ashina has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Ashina has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Ashina has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Ashina has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Ashina has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer.
Francoise Bouhour	No disclosure on file
Barbara Nuesslein-Hildesheim, PhD	Dr. Nuesslein-Hildesheim has received personal compensation for serving as an employee of Novartis Pharma AG. Dr. Nuesslein-Hildesheim has stock in Novartis Pharma AG.
Dong Jin Shin, MD	Dr. Shin has nothing to disclose.
Pooja Khatri, MD, F�鶹��ýӳ��	Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lumosa. Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL. Dr. Khatri has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Basking Biosciences. Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Silvercreek. The institution of Dr. Khatri has received research support from NIH/NINDS. The institution of Dr. Khatri has received research support from AHA. The institution of Dr. Khatri has received research support from Cerenovus. Dr. Khatri has received publishing royalties from a publication relating to health care.
Hacer Durmus, MD	Dr. Durmus has nothing to disclose.
Joseph Herbert, MD	No disclosure on file
Andrew L. Lin, MD	The institution of Dr. Lin has received research support from Bristol Myers Squibb. The institution of Dr. Lin has received research support from NantOmics. The institution of Dr. Lin has received research support from Society of Memorial Sloan Kettering Cancer Center.
Nimish A. Mohile, MD, F�鶹��ýӳ��	The institution of Dr. Mohile has received research support from Novocure.
Kenkichi Nozaki, MD	No disclosure on file
Fazeel M. Siddiqui, MD	No disclosure on file
Judith Stephenson	No disclosure on file
Daniel Woo, MD, F�鶹��ýӳ��	The institution of Dr. Woo has received research support from NIH.
Staley A. Brod, MD	Dr. Brod has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Brod has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi.
Kate Busby, MD	No disclosure on file
Rodger J. Elble, MD, PhD, F�鶹��ýӳ��	Dr. Elble has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz. Dr. Elble has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage . Dr. Elble has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ES Therapeutics. Dr. Elble has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Applied Therapeutics. Dr. Elble has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Praxis.
Neeta Garg, MD	Dr. Garg has nothing to disclose.
Victoria Lawson, MD, F�鶹��ýӳ��	Dr. Lawson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
David P. Libell, MD, F�鶹��ýӳ��	No disclosure on file
Sunitha Santhakumar, MD	No disclosure on file
Jean-Sebastien Vidal	No disclosure on file
Bianca Weinstock-Guttman, MD	Dr. Weinstock-Guttman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme &Sanofi. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH.
Deborah H. Hall, MD, PhD, F�鶹��ýӳ��	Dr. Hall has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for �鶹��ýӳ��. Dr. Hall has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier - Parkinsonism and Related Disorders. Dr. Hall has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. The institution of Dr. Hall has received research support from Parkinson's Foundation. The institution of Dr. Hall has received research support from CHDI. The institution of Dr. Hall has received research support from Uniqure. The institution of Dr. Hall has received research support from NIH.
Nada G. Abou Fayssal, MD, F�鶹��ýӳ��	Dr. Abou Fayssal has nothing to disclose.
Opeolu Adeoye	No disclosure on file
Judith Bellmann-Strobl, MD	Judith Bellmann-Strobl, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Judith Bellmann-Strobl, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Judith Bellmann-Strobl, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Judith Bellmann-Strobl, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Judith Bellmann-Strobl, MD has received research support from Bayer. The institution of Judith Bellmann-Strobl, MD has received research support from NEMOS.
John Q. Trojanowski, MD, PhD	Dr. Trojanowski has nothing to disclose.
Brian G. Weinshenker, MD, F�鶹��ýӳ��	Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharmaceuticals. Dr. Weinshenker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zenas Pharma. Dr. Weinshenker has received research support from Guthy Jackson Charitable Foundation. Dr. Weinshenker has received intellectual property interests from a discovery or technology relating to health care.
Enrico Ferrante	No disclosure on file
Xiang Gao, MD, PhD	Dr. Gao has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Nutrition Journal. The institution of Dr. Gao has received research support from NIH.
Valerie Jaillon Riviere, MD	No disclosure on file
Daniel M. Harrison, MD, F�鶹��ýӳ��	Dr. Harrison has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics. Dr. Harrison has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American College of Physicians. The institution of Dr. Harrison has received research support from Roche-Genentech. Dr. Harrison has received publishing royalties from a publication relating to health care.
Ilya Kister, MD, F�鶹��ýӳ��	Dr. Kister has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech-Roche. Dr. Kister has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Kister has received research support from Genentech. The institution of Dr. Kister has received research support from Novartis. Dr. Kister has received publishing royalties from a publication relating to health care.
Helen Papageorgiou, MD	No disclosure on file
Chris H. Polman, MD	No disclosure on file
Denise H. Rhoney, PhD	No disclosure on file
Lucien Rumbach, MD	No disclosure on file
Robert Spinner	No disclosure on file
James Stark, MD, F�鶹��ýӳ��	Dr. Stark has nothing to disclose.
Annie Verschueren	No disclosure on file
Christopher J. Boes, MD, F�鶹��ýӳ��	Dr. Boes has a non-compensated relationship as a Review Committee for Neurology member with ACGME that is relevant to �鶹��ýӳ�� interests or activities.
Elizabeth A. Hartman, MD	An immediate family member of Dr. Hartman has or had stock in Amgen.
Sebastian Humpert, MD	No disclosure on file
Daniel A. Mandel, PhD	No disclosure on file
Michelle L. Mellion, MD	Dr. Mellion has received personal compensation for serving as an employee of PepGen. Dr. Mellion has stock in PepGen.
Daniel Mielcarz	No disclosure on file
Angelika F. Hahn, MD, FRCP(C)	No disclosure on file
Gail H. Marracci, PhD	No disclosure on file
Fadi B. Nahab, MD	Dr. Nahab has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Legal Consultation. Dr. Nahab has received intellectual property interests from a discovery or technology relating to health care.
Otto Pedraza	The institution of Otto Pedraza has received research support from Alzheimer's Association. Otto Pedraza has received publishing royalties from a publication relating to health care.
Huijun Wang, MD, PhD	No disclosure on file
Conrad Weihl, MD, PhD	Dr. Weihl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Dr. Weihl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Casma therapeutics. Dr. Weihl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abata. Dr. Weihl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Weihl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Weihl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acceleron. Dr. Weihl has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Wilson Elser Moskowitz Edelman & Dicker LLP.
Andrew Ho	No disclosure on file
Aaron P. Kithcart	No disclosure on file
Glenn Lopate, MD	Dr. Lopate has nothing to disclose.
Obinna I. Moneme, MD	No disclosure on file
Kimberly H. Oas, RN, MSN	No disclosure on file
Pamela Rist, PhD	The institution of Dr. Rist has received research support from National Institutes of Health. The institution of Dr. Rist has received research support from Brigham and Women's Hospital. The institution of Dr. Rist has received research support from American Heart Association. The institution of Dr. Rist has received research support from Mars Edge.
Andrea L. Rosso, MPH	No disclosure on file
Hayrettin Tumani, MD	Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva.
Jennifer N. Serventi, PA	Ms. Serventi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novocure.
Muhammad F. Suri, MD	Dr. Suri has nothing to disclose.
Richard Walsh, MD	Dr. Walsh has nothing to disclose.
James M. Gilchrist, MD, F�鶹��ýӳ��	Dr. Gilchrist has received publishing royalties from a publication relating to health care.
Markus Schuerks, MD, F�鶹��ýӳ��	No disclosure on file
Harirama K. Acharya, MD	No disclosure on file
Ghazala Hayat, MBBS, F�鶹��ýӳ��	Dr. Hayat has received personal compensation in the range of $500-$4,999 for serving as a Consultant for kabafusion. Dr. Hayat has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for csl. Dr. Hayat has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for alexion. Dr. Hayat has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for MTPA. Dr. Hayat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for alexion. Dr. Hayat has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for kabafusion.
Thien T. Nguyen, MD	No disclosure on file
William Rooney, PhD	Dr. Rooney has nothing to disclose.
Dawn O. Kleindorfer, MD, F�鶹��ýӳ��	Dr. Kleindorfer has nothing to disclose.
Sylvia M. Lucas, MD, PhD	No disclosure on file
Brett M. Kissela, MD, MS, F�鶹��ýӳ��	The institution of Dr. Kissela has received research support from NIH/NINDS. Dr. Kissela has a non-compensated relationship as a Board Member with AHA Regional Board that is relevant to �鶹��ýӳ�� interests or activities.
Meetu Bhogal, MSc	No disclosure on file
Maame Dankwah, MD	No disclosure on file
Alexandre Eusebio, MD	No disclosure on file
Peter H. King, MD	The institution of Dr. King has received research support from Department of Veterans Affairs. The institution of Dr. King has received research support from NIH.
Peter Schnabl, MD	No disclosure on file
Douglas Feinstein, MD	No disclosure on file
Tracey D. Graves, MD, PhD, FRCP	No disclosure on file
Ulrich Hofstadt-van Oy, MD	No disclosure on file
Sara Khan, MD	Dr. Khan has nothing to disclose.
Olga Sanchez Solino, MD	Dr. Sanchez Solino has received personal compensation for serving as an employee of AbbVie. Dr. Sanchez Solino has received stock or an ownership interest from AbbVie.
Massimo Filippi, MD, F�鶹��ýӳ��	Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Tobias Kurth, MD, ScD, F�鶹��ýӳ��	Dr. Kurth has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TotalEnergies. Dr. Kurth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly & Company. Dr. Kurth has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BMJ. Dr. Kurth has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers. The institution of Dr. Kurth has received research support from German Joint Committee. The institution of Dr. Kurth has received research support from Ministry of Health.
Marianne C. Cunnington, PhD	No disclosure on file
Minesh Khatri	No disclosure on file
Carly B. Oboudiyat, MD	No disclosure on file
Mamatha Pasnoor, MD, F�鶹��ýӳ��	Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx BVBA. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceutical. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for amgen.
Edward Avila, DO, F�鶹��ýӳ��	Dr. Avila has received publishing royalties from a publication relating to health care.
Kyra J. Becker, MD	No disclosure on file
Thomas A. Berger, MD	Prof. Berger has received personal compensation in the range of $10,000-$49,999 for serving as a speaker at scientific meetings and participant of local and international advisory boards with various companies producing and markerting treatments for multiple sclerosis (Almirall, Biogen, Biologix, Bionorica, Celgene-BMS, Merck, Novartis, Roche, Sanofi-Genzyme, TG Therapeutics, UCB).
Peter J. Dyck, MD, F�鶹��ýӳ��	Dr. Dyck has nothing to disclose.
Simona Ferioli, MD	Dr. Ferioli has nothing to disclose.
Mario Halfon	No disclosure on file
Paul G. Mathew, MD, DNBPAS, FAHS, FACSM, F�鶹��ýӳ��	Dr. Mathew has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie/Allergan. Dr. Mathew has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Mathew has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven/Pfizer. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Upsher Smith. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Mathew has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie.
Shivani C. Patel	No disclosure on file
Cynthia L. Sullivan, PhD	No disclosure on file
Douglas A. Wright, MD	No disclosure on file
Hussam A. Yacoub, DO	Dr. Yacoub has nothing to disclose.
Sean Taylor, MD	No disclosure on file
Prashanthi Vemuri, PhD	The institution of Dr. Vemuri has received research support from NIH.
Xiaojun You, PhD	No disclosure on file
Christine Stadelmann-Nessler	No disclosure on file
Lael Stone, MD	No disclosure on file
Josephine K. Swanton, MD	No disclosure on file
Robert Tiel, MD	No disclosure on file
Patricia Tourniaire, MD	No disclosure on file
Tresa Zacharias, MD	An immediate family member of Dr. Zacharias has received personal compensation for serving as an employee of HCSC. Dr. Zacharias has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Liberty Mutual. Dr. Zacharias has received publishing royalties from a publication relating to health care.
Tjalf Ziemssen, MD, F�鶹��ýӳ��	Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS . Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Dresden Internation University. The institution of Dr. Ziemssen has received research support from Novartis. The institution of Dr. Ziemssen has received research support from Merck. The institution of Dr. Ziemssen has received research support from Sanofi. The institution of Dr. Ziemssen has received research support from BMS. The institution of Dr. Ziemssen has received research support from Roche.
Chamindra G. Laverty, MD	The institution of Dr. Laverty has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sarepta . Dr. Laverty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Laverty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Catalyst. Dr. Laverty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Solid Biosciences. Dr. Laverty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. The institution of Dr. Laverty has received research support from Sarepta. The institution of Dr. Laverty has received research support from Novartis Gene Therapies. The institution of Dr. Laverty has received research support from Italfarmaco. The institution of Dr. Laverty has received research support from Fibrogen. The institution of Dr. Laverty has received research support from Avidity. The institution of Dr. Laverty has received research support from Dyne.
Brajesh K. Agrawal, MD	No disclosure on file
Fortunato Battaglia, MD	Dr. Battaglia has nothing to disclose.
Jason Huse	No disclosure on file
Joerg R. Kraus, MD	No disclosure on file
Wolfgang Kristoferitsch, MD	No disclosure on file
Aubrey Adams, PhD	Dr. Manack Adams has received personal compensation for serving as an employee of Abbvie. Dr. Manack Adams has stock in Abbvie.
Martin Marziniak, PhD	No disclosure on file
Dominick J. McCabe, MD, PhD	No disclosure on file
Juan C. Parra Riaza	Juan C. Parra Riaza has received personal compensation for serving as an employee of AbbVie INC. Juan C. Parra Riaza has stock in AbbVie INC.
Haythum O. Tayeb, MD	Dr. Tayeb has nothing to disclose.
Frederick J. Derosier, DO	No disclosure on file
Robert J. Fallis, MD	No disclosure on file
Shannon Kohake, MD	No disclosure on file
Stacy S. Wu, MD	Dr. Wu has received personal compensation for serving as an employee of Sunovion Pharmaceuticals Inc. Dr. Wu has stock in Novartis.
Lixin Zhang-Auberson, MD, PhD	No disclosure on file
Alan J. Thompson, MD, FRCP, F�鶹��ýӳ��	No disclosure on file
Matthew E. Tilem, MD	An immediate family member of Dr. Tilem has received personal compensation in the range of $100,000-$499,999 for serving as a Attorney with Pharmaceutical companies (confidential).
Dimitrios Tzortzis	No disclosure on file
Shahamat Tauhid, MD	Dr. Tauhid has nothing to disclose.
Christiane Wegner, MD	No disclosure on file
Sibyl E. Wray, MD	Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb/Celgene. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Roche/Genentech. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi/Genzyme. The institution of Dr. Wray has received research support from Biogen. The institution of Dr. Wray has received research support from Atara Biotherapeutics. The institution of Dr. Wray has received research support from Bristol Myers Squibb/Celgene. The institution of Dr. Wray has received research support from Novartis. The institution of Dr. Wray has received research support from Roche/Genentech. The institution of Dr. Wray has received research support from Sanofi/Genzyme. The institution of Dr. Wray has received research support from TG Therapeutics. The institution of Dr. Wray has received research support from EMD Serono. The institution of Dr. Wray has received research support from Pharmaceuticals Corp..
Sebastian Zaremba, MD	No disclosure on file
Ikuo Tsunoda, PhD	No disclosure on file
Armistead Williams III, MD	Dr. Williams has nothing to disclose.
Timothy E. Lotze, MD, F�鶹��ýӳ��	Dr. Lotze has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Department of Justice VICP. The institution of Dr. Lotze has received research support from NIH. The institution of Dr. Lotze has received research support from National MS Society. The institution of Dr. Lotze has received research support from Sarepta Therapeutics. The institution of Dr. Lotze has received research support from PTC THERAPEUTICS. The institution of Dr. Lotze has received research support from Avexis. Dr. Lotze has received publishing royalties from a publication relating to health care. Dr. Lotze has received publishing royalties from a publication relating to health care.
Carlos A. Teixeira, MD	No disclosure on file
Sofia Tsiara, MD	No disclosure on file
Samuel Singer, MD	Dr. Singer has nothing to disclose.
Leslie B. Williams, MD	No disclosure on file
Nicolette C. Notermans, MD, PhD	No disclosure on file
Elias Olafsson, MD, PhD	No disclosure on file
Ivo W. Tremont, MD, F�鶹��ýӳ��	Dr. Tremont has nothing to disclose.
Nancy D. Richert, MD, PhD	No disclosure on file
Nerses Sanossian, MD, F�鶹��ýӳ��	Dr. Sanossian has received personal compensation for serving as an employee of Univeristy of Southern California. Dr. Sanossian has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Sanossian has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Sanossian has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Portola. The institution of Dr. Sanossian has received research support from Diffusion Pharma.
Zohara Sternberg, PhD	No disclosure on file
Panayiota Petrou	No disclosure on file
Sarah Sahib	No disclosure on file
Michael Wall, MD, F�鶹��ýӳ��	No disclosure on file
Erin K. O'Ferrall, MD	The institution of Dr. O'Ferrall has received research support from Sanofi Genzyme. The institution of Dr. O'Ferrall has received research support from Harmony Biosciences. The institution of Dr. O'Ferrall has received research support from Fulcrum Therapeutics. The institution of Dr. O'Ferrall has received research support from Roche Pharmaceuticals. The institution of Dr. O'Ferrall has received research support from VERTEX. The institution of Dr. O'Ferrall has received research support from Novartis. Dr. O'Ferrall has received publishing royalties from a publication relating to health care.
Carlos A. Pardo-Villamizar, MD	The institution of Dr. Pardo-Villamizar has received research support from National Institutes of Health. The institution of Dr. Pardo-Villamizar has received research support from Bart McLean Fund for Neuroimmunology Research .
Michael Sinnreich, MD, PhD	Prof. Sinnreich has nothing to disclose.
Dinah Thyerlei, MD, F�鶹��ýӳ��	No disclosure on file
Anna Tsakiri, MD	No disclosure on file
Pieter Van Doorn, MD	The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hansa. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Octapharma. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Grifols. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Octapharma. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Van Doorn has received publishing royalties from a publication relating to health care.
Jordan S. Reichman, MD	No disclosure on file
Theodore Wein, MD	No disclosure on file
Waldo Guerrero, MD	Dr. Guerrero has nothing to disclose.
Kenneth J. Mack, MD, PhD, F�鶹��ýӳ��	Dr. Mack has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Mack has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Mack has received publishing royalties from a publication relating to health care. Dr. Mack has received personal compensation in the range of $5,000-$9,999 for serving as a Expert Witness with Department of Justice, DVIC.
Michael McDermott	No disclosure on file
Nancy Monson	Nancy Monson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech, Inc.. Nancy Monson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GenrAb, Inc.. Nancy Monson has stock in GenrAb, Inc.. The institution of Nancy Monson has received research support from NIH. Nancy Monson has received intellectual property interests from a discovery or technology relating to health care.
Leonard van den Berg, MD	The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ferrrer. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Projenx. Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept. The institution of Dr. Van den Berg has received research support from Netherlands ALS Foundation.
Bing Zhu	No disclosure on file
Christopher C. LaGanke, MD	Dr. LaGanke has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. LaGanke has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. LaGanke has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. LaGanke has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi. Dr. LaGanke has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Dr. LaGanke has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for GSK. Dr. LaGanke has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Serono EMD. Dr. LaGanke has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. LaGanke has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. LaGanke has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutics.
Ingemar S. Merkies, MD	No disclosure on file
Michael J. Turner, PhD	No disclosure on file
James F. Sumowski	Mr. Sumowski has nothing to disclose.
Catherine C. Turkel, Pharm	No disclosure on file
Bruce Roberts, PhD	No disclosure on file
Bilal Saulat, MD	No disclosure on file
Seyed Ali Sonbolestan, MD	No disclosure on file
Erica Rojas-Bilbao, MD	No disclosure on file
William M. Siders, PhD	No disclosure on file
Ivo N. Van Schaik, MD	No disclosure on file
Virginia J. Howard, PhD	The institution of Dr. Howard has received research support from NIH. The institution of an immediate family member of Dr. Howard has received research support from NIH.
Melina Jones, PhD	No disclosure on file
Johanne M. Kaplan, PhD	Dr. Kaplan has received personal compensation for serving as an employee of ProMIS Neurosciences. Dr. Kaplan has stock in ProMIS Neurosciences. Dr. Kaplan has received intellectual property interests from a discovery or technology relating to health care.
Carol L. Koski, MD	No disclosure on file
Pedro A. Kowacs, MD, F�鶹��ýӳ��	Dr. Kowacs has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis.
Henry F. McFarland, MD	Dr. McFarland has received intellectual property interests from a discovery or technology relating to health care. Dr. McFarland has received personal compensation in the range of $50,000-$99,999 for serving as a Medical Director with Cumming Foundation.
Allyson Parry	No disclosure on file
Annette Wundes, MD, F�鶹��ýӳ��	The institution of Dr. Wundes has received research support from Benaroya Research Institute .
Joseph E. Parisi, MD	Dr. Parisi has nothing to disclose.
Stephanie Scala	No disclosure on file
Jose G. Speciali, MD	No disclosure on file
Dusan Stefoski, MD, F�鶹��ýӳ��	No disclosure on file
Jennifer L. Reardon	Jennifer L. Reardon has received personal compensation for serving as an employee of Bristol Myers Squibb.
Alan Z. Segal, MD, F�鶹��ýӳ��	Dr. Segal has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Various Law Firms. Dr. Segal has received publishing royalties from a publication relating to health care.
Jennifer J. Majersik, MD, F�鶹��ýӳ��	Dr. Majersik has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke. The institution of Dr. Majersik has received research support from NIH/NINDS. The institution of Dr. Majersik has received research support from NIH/NCATS.
Marco Riva	No disclosure on file
Marie-Laure Santiago-Raber, PhD	No disclosure on file
April H. Thompson	No disclosure on file
W. T. Longstreth, Jr., MD, F�鶹��ýӳ��	The institution of Dr. Longstreth has received research support from NIH.
Amy Pace, ScD	No disclosure on file
Reva C. Wilheim	No disclosure on file
Minhua Yang	No disclosure on file
Min-Suk Yoon, MD	No disclosure on file
Lan Zhou, MD, PhD	The institution of Dr. Zhou has received research support from NIH.
Mario O. Melcom, MD	No disclosure on file
B. L. Peterlin, DO	Dr. Peterlin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Peterlin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for J&J. Dr. Peterlin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Peterlin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Peterlin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Dr. Peterlin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Peterlin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan.
Chase Petersen	No disclosure on file
Piraye Serdaroglu, MD	No disclosure on file
Negar Sodeifi, MD	No disclosure on file
Nathan P. Staff, MD, PhD, F�鶹��ýӳ��	Dr. Staff has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stem Cell Research & Therapy. Dr. Staff has received research support from National Institutes of Health.
Joreg R. Weber	No disclosure on file
Martin Weygandt, PhD	No disclosure on file
David G. Munoz, MD	No disclosure on file
Anne M. Murray, MD	No disclosure on file
Jeong-Ho Park, MD	No disclosure on file
Sanne Piepers	No disclosure on file
James C. Watson, MD	No disclosure on file
Crystal G. Wheeler	No disclosure on file
Julian Zimmermann	No disclosure on file
Eduardo Nobile-Orazio, MD, PhD, F�鶹��ýӳ��	Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX, Belgium. Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LFB, France. Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche, Switzerland. Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen, USA. The institution of Dr. Nobile-Orazio has received research support from Takeda/Shire.
Eva Havrdova, MD	Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Steven K. Baker, MD	Dr. Baker has nothing to disclose.
Roberto D'Alessandro, MD	No disclosure on file
David Dolezil	No disclosure on file
Lars G. Edstrom, MD, F�鶹��ýӳ��	No disclosure on file
Jerome Franques, MD	No disclosure on file
Michelle Greer	No disclosure on file
Karen Marr, BA	No disclosure on file
Steven R. Messe, MD, FAHA, F�鶹��ýӳ��	Dr. Messe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novo Nordisk. Dr. Messe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Terumo. Dr. Messe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for WL Gore. The institution of Dr. Messe has received research support from WL Gore. The institution of Dr. Messe has received research support from Mallinkrodt. The institution of Dr. Messe has received research support from Biogen. Dr. Messe has received intellectual property interests from a discovery or technology relating to health care. Dr. Messe has received publishing royalties from a publication relating to health care. Dr. Messe has received personal compensation in the range of $500-$4,999 for serving as a Clinical Event Committee for the CONFORMAL left atrial appendage occlusion trial with Yale Cardiovascular Research Group.
Najib I. Murr, MD, F�鶹��ýӳ��	Dr. Murr has nothing to disclose.
Ute Pohl, MD	No disclosure on file
Vahid Shaygan Nejad, MD	Dr. Shaygan Nejad has nothing to disclose.
Fred D. Sheftell, MD	No disclosure on file
Cory Teuscher, PhD	No disclosure on file
Karen Truitt, DO	Dr. Truitt has stock in QTRX. Dr. Truitt has stock in EXAS. Dr. Truitt has stock in ACAD. Dr. Truitt has stock in ABBV. Dr. Truitt has stock in NVS. Dr. Truitt has stock in VRTX. Dr. Truitt has stock in MRK.
Karine Viala	No disclosure on file
Chad Whyte, MD	No disclosure on file
Jeffrey A. Wilken, PhD	No disclosure on file
Hasan Askari, MD	No disclosure on file
Regina Berkovich, MD, PhD	The institution of Dr. Berkovich has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Alexion, Biogen, Genentec, Mallincrodt, Sanofi, Novartis, . Dr. Berkovich has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, Genentec, Sanofi, Merck . Dr. Berkovich has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion, Biogen, Sanofi, Merck, Mallincrodt . The institution of Dr. Berkovich has received research support from Biogen, Sanofi, Merck.
Theodore R. Brown, MD	Dr. Brown has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Astellas. The institution of Dr. Brown has received research support from Merck.
Charlene R. Hoffman-Snyder, DNP	No disclosure on file
Charles Maitland	No disclosure on file
William F. Schmalstieg, MD	No disclosure on file
Andrew R. Pachner, MD	No disclosure on file
Dante Facchetti	No disclosure on file
Aaron J. Johnson	No disclosure on file
Anli Liu, MD	Dr. Liu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ECRI. Dr. Liu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neuropace Inc.
Dimitrios Papadopoulos, MD	No disclosure on file
Elena Pentsova, MD	The institution of Dr. Pentsova has received research support from YmAbs Therapeutics, Inc.
Eliana Rodillo, MD	No disclosure on file
Radi S. Shahien, MD	Dr. Shahien has nothing to disclose.
Tracy E. Stites, PhD	Dr. Stites has received personal compensation for serving as an employee of Novartis Pharmaceuticals. Dr. Stites has received stock or an ownership interest from Novartis Pharmaceuticals.
A. Gordon Smith, MD, F�鶹��ýӳ��	Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merz. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for US Department of Justice. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Smith has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Eidos. Dr. Smith has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Lexicon. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. The institution of Dr. Smith has received research support from NIH (NINDS, NIDDK). Dr. Smith has received publishing royalties from a publication relating to health care. Dr. Smith has received personal compensation in the range of $0-$499 for serving as a Study Section with NIH.
Lisa Silbert, MD, F�鶹��ýӳ��	The institution of Dr. Silbert has received research support from the NIH. Dr. Silbert has received personal compensation in the range of $0-$499 for serving as a Peer Reviewer, study section with NIH.
Emma Ciafaloni, MD, F�鶹��ýӳ��	Dr. Ciafaloni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx, Alexion, Sarepta, UCB, Hoffman-LaRoche, Biogen. Dr. Ciafaloni has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis, AnnJi Pharmaceutical, ML-BIO, Avidity. The institution of Dr. Ciafaloni has received research support from CDC, CureSMA, FDA, Orphazyme, Sarepta, PCORI, Neurogene. Dr. Ciafaloni has received publishing royalties from a publication relating to health care.
Elisa Canu	The institution of Elisa Canu has received research support from Italian Ministry of Health .
Min Kyung Chu, MD, PhD	No disclosure on file
Olivier Heinzlef, MD	Dr. Heinzlef has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Heinzlef has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Heinzlef has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Edimark.
Christine A. Matarese, DO	No disclosure on file
Andre Maues De Paula, MD, PhD	No disclosure on file
Dimos Dimitrios D. Mitsikostas, MD, PhD	The institution of Dr. Mitsikostas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. The institution of Dr. Mitsikostas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Mitsikostas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. The institution of Dr. Mitsikostas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Leli Lilly. The institution of Dr. Mitsikostas has received research support from Eli Lilly. Dr. Mitsikostas has a non-compensated relationship as a Co-Chair of Headache Panel with EAN that is relevant to �鶹��ýӳ�� interests or activities. Dr. Mitsikostas has a non-compensated relationship as a President with Hellenic Headache Society that is relevant to �鶹��ýӳ�� interests or activities. Dr. Mitsikostas has a non-compensated relationship as a Associate Editor with J Headache Pain that is relevant to �鶹��ýӳ�� interests or activities. Dr. Mitsikostas has a non-compensated relationship as a Associate Editor with Frontier Neurology that is relevant to �鶹��ýӳ�� interests or activities.
Earl A. Zimmerman, MD, F�鶹��ýӳ��	No disclosure on file
Peter Wipfler	Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS/Celgene. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Mona Bahouth, MD, PhD, F�鶹��ýӳ��	Dr. Bahouth has nothing to disclose.
Ajay M. Tunguturi, MD	Dr. Tunguturi has nothing to disclose.
Laura F. Santoso	No disclosure on file
Mamta Verma, MD	No disclosure on file
Michelle Rainka, PharmD	Dr. Rainka has stock in Abbvie. Dr. Rainka has stock in acadia. Dr. Rainka has stock in alon. Dr. Rainka has stock in biogen. Dr. Rainka has stock in bristol myers squib. Dr. Rainka has stock in eisai. Dr. Rainka has stock in Lilly. Dr. Rainka has stock in novartis. Dr. Rainka has stock in pfizer. Dr. Rainka has stock in roche. Dr. Rainka has stock in Sage. Dr. Rainka has stock in alkermes.
Cinthi Pillai, MD	Dr. Pillai has nothing to disclose.
Alexandra Dimitrova, MD	Dr. Dimitrova has nothing to disclose.
Brenton A. Wright, MD	Dr. Wright has nothing to disclose.
Charlene E. Hafer-Macko, MD	No disclosure on file
Zurab Nadareishvili, MD, PhD	No disclosure on file
Rajsekar R. Rajaraman, MD	Dr. Rajaraman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Marinus Pharmacueticals.
Vijay A. Vishwanath, MD, PhD	No disclosure on file
Cathy Chuang, MD	No disclosure on file
Pablo B. Winckler, MD, PhD	Dr. Winckler has nothing to disclose.
Jurriaan Peters, MD	Dr. Peters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals. Dr. Peters has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis. Dr. Peters has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for CRICO. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for UCB.
Richard P. Goddeau, Jr., DO	No disclosure on file
Abdullah Tawakul, MD	No disclosure on file
Juliana Calvet Kallenbach Aurencao	No disclosure on file
Louis Manganas, MD, PhD	No disclosure on file
Erin Furr-Stimming, MD, F�鶹��ýӳ��	Dr. Furr-Stimming has received personal compensation for serving as an employee of Help4HD International. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedPage. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave Life Sciences. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Latus Bio. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atalanta Therapeutics. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SkyHawk Therapeutics. The institution of Dr. Furr-Stimming has received research support from Roche/Genetech. The institution of Dr. Furr-Stimming has received research support from Uniqure. The institution of Dr. Furr-Stimming has received research support from CHDI. The institution of Dr. Furr-Stimming has received research support from Huntington Study Group/Neurocrine Bioscienes. The institution of Dr. Furr-Stimming has received research support from NIH/University of Iowa. The institution of Dr. Furr-Stimming has received research support from HDSA. Dr. Furr-Stimming has received publishing royalties from a publication relating to health care. Dr. Furr-Stimming has received publishing royalties from a publication relating to health care. Dr. Furr-Stimming has a non-compensated relationship as a Committee member with �鶹��ýӳ�� UES Committee that is relevant to �鶹��ýӳ�� interests or activities.
Munro Cullum, PhD	The institution of Dr. Cullum has received research support from NIH. Dr. Cullum has received intellectual property interests from a discovery or technology relating to health care. Dr. Cullum has received personal compensation in the range of $10,000-$49,999 for serving as a Scientific Director with Texas Alzheimers Research and Care Consortium.
Guannan Ge, MD	No disclosure on file
Athari K. Salmeen, MD	No disclosure on file
Channa Kolb, MD	No disclosure on file
Elizabeth R. DeGrush, DO	Dr. DeGrush has nothing to disclose.
Keith Van Haren, MD	Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viking Therapeutics. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bluebirdbio. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orpheris. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Autobahn. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for PRIME, Inc. The institution of Dr. Van Haren has received research support from Minoryx. The institution of Dr. Van Haren has received research support from bluebirdbio. Dr. Van Haren has a non-compensated relationship as a Board of Directors with ALD Connect that is relevant to �鶹��ýӳ�� interests or activities. Dr. Van Haren has a non-compensated relationship as a Scientific Advisory Board with United Leukodystrophy Foundation that is relevant to �鶹��ýӳ�� interests or activities.
Phillip D. Swanson, MD	No disclosure on file
Conrad Liang, MD	Dr. Liang has nothing to disclose.
Wiley Hall, MD	No disclosure on file
Mindy A. Aisen, MD	No disclosure on file
Trung P. Nguyen, MD	The institution of Dr. Nguyen has received research support from National Institute on Aging. The institution of Dr. Nguyen has received research support from Texas Alzheimer's Research and Care Consortium. The institution of Dr. Nguyen has received research support from Biogen.
Nagbhushan S. Rao, MD, F�鶹��ýӳ��	No disclosure on file
Ryan Coates, MD	No disclosure on file
Patricia L. Henegan	No disclosure on file
Shnehal Patel, MD	Dr. Patel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Patel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Patel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Adamas. Dr. Patel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine.
Luci Blasucci, RN	No disclosure on file
Adnan Safdar, MD	Dr. Safdar has nothing to disclose.
Hokuto Morita, MD	No disclosure on file
Tarvez Tucker, MD	No disclosure on file
Kimberly D. Johnson, MD	No disclosure on file
Marta Simone	Marta Simone, 11772 has nothing to disclose.
Jorge G. Ortiz-Garcia, MD, F�鶹��ýӳ��	Dr. Ortiz-Garcia has nothing to disclose.
Priyanka Sabharwal, MD, MBBS, F�鶹��ýӳ��	Dr. Sabharwal has nothing to disclose.
Robin L. Avila, PhD	Mrs. Avila has received personal compensation for serving as an employee of Biogen. Mrs. Avila has stock in Biogen.
Toby I. Gropen, MD	Dr. Gropen has nothing to disclose.
David M. Burke, MD	No disclosure on file
Vijay M. Thadani, MD	No disclosure on file
Carolyn Schwartz, ScD	No disclosure on file
Kanika Arora, MD	No disclosure on file
Rachel Salzman, DVM	No disclosure on file
Dino Maglic	No disclosure on file
Claudia J. Chaves, MD, F�鶹��ýӳ��	No disclosure on file
Peggy Nguyen, MD	Dr. Nguyen has nothing to disclose.
John Cole, MD	Dr. Cole has nothing to disclose.
Alexandra C. Boske, MD	Dr. Boske has nothing to disclose.
Seyed Aidin Sajedi	No disclosure on file
Jennifer R. Friedman, MD	An immediate family member of Dr. Friedman has received personal compensation in the range of $0-$499 for serving as a Consultant for Sinopia Biosciences. An immediate family member of Dr. Friedman has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Pet Dx. Dr. Friedman has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. Dr. Friedman has stock in Friedman Bioventure .
Onjin Kim, MD	No disclosure on file
Dasha Kenlan	No disclosure on file
Kyung-Wha Kim, MD	No disclosure on file
Gowri Lakshminarayan, MD	No disclosure on file
Pamela Delgado	No disclosure on file
Victor Wang, MD, F�鶹��ýӳ��	Dr. Wang has nothing to disclose.
Michal Vytopil, MD	Dr. Vytopil has nothing to disclose.
Neil W. Kowall, MD	Dr. Kowall has received publishing royalties from a publication relating to health care.
Sami Saba, MD	Dr. Saba has nothing to disclose.
Ann C. McKee, MD	Dr. McKee has nothing to disclose.
Sudhir V. Datar, MD	Dr. Datar has nothing to disclose.
Chih-Wei Tang, MD	No disclosure on file
Ahmed A. Malik, MD	No disclosure on file
Martin D. Ollenschleger, MD	No disclosure on file
Carlo Cereda, MD	No disclosure on file
Scott Przybelski	Scott Przybelski has nothing to disclose.
M. M. Paz Soldan, MD, PhD	Dr. Paz Soldan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Paz Soldan has received research support from National Institutes of Health. The institution of Dr. Paz Soldan has received research support from National Multiple Sclerosis Society. The institution of Dr. Paz Soldan has received research support from Western Institute for Biomedical Research. The institution of Dr. Paz Soldan has received research support from Biogen. The institution of Dr. Paz Soldan has received research support from Novartis. The institution of Dr. Paz Soldan has received research support from Clene Nanomedicine.
Jonathan D. Victor, MD, PhD	No disclosure on file
Kerri S. Remmel, MD, PhD	Dr. Remmel has nothing to disclose.
Lakshmi Warrior, MD, F�鶹��ýӳ��	Dr. Warrior has nothing to disclose.
Malgorzata Wiszniewska	No disclosure on file
Alicja Lerner, MD	No disclosure on file
Nora Vanegas-Arroyave, MD	The institution of Dr. Vanegas-Arroyave has received research support from National Institutes of Health. The institution of Dr. Vanegas-Arroyave has received research support from MJFF.
Kevin Messacar, MD	No disclosure on file
Elisabeth G. Kramer, MD	No disclosure on file
Dimitrios I. Zafeiriou, MD, PhD	No disclosure on file
Francisco Sales, MD	No disclosure on file
Haris Kamal, MD	Dr. Kamal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Microvention .
Meghan Candee, MD	Dr. Candee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Finn Partners Marketing.
Jaskiran Brar, MD	No disclosure on file
Krisztina Harsanyi, MD	No disclosure on file
Jussara M. Khouri, MD	Dr. Khouri has nothing to disclose.
Lidia Sarro, MD	No disclosure on file
Andrew Welleford, MD, PhD	Dr. Welleford has nothing to disclose.
Amy K. Guzik, MD, F�鶹��ýӳ��	Dr. Guzik has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Local law firms, available by request.
Andrew Bursaw, DO	No disclosure on file
Carl A. Gold, MD, F�鶹��ýӳ��	Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a CME Course Presenter with Oakstone.
Lee S. Chung, MD	Dr. Chung has nothing to disclose.
Harina K. Chahal, MD	No disclosure on file
Assad F. Amin, MD	No disclosure on file
Drini Dobi, MD, PhD	No disclosure on file
Breyanna N. Grays, MD	No disclosure on file
Robert Cantu, MD	Dr. Cantu has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Multiple law firms .
George J. Snipes, MD	No disclosure on file
Michele Yang, MD	The institution of Dr. Yang has received research support from Janssen. The institution of Dr. Yang has received research support from Edgewise. The institution of Dr. Yang has received research support from ReveraGen.
Richard D. Dortch, PhD	Dr. Dortch has nothing to disclose.
David Langer, MD	No disclosure on file
Brian McNamara, MD	Dr. McNamara has nothing to disclose.
Mary Carter Denny, MD	Dr. Denny has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbott Laboratory. The institution of Dr. Denny has received research support from NIDDILIR. Dr. Denny has received publishing royalties from a publication relating to health care.
Lidia Maria V. Moura, MD, PhD, MPH, F�鶹��ýӳ��	Dr. Moura has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Moura has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. The institution of Dr. Moura has received research support from Centers for Diseases Control and Prevention (CDC SIP20-007) . The institution of Dr. Moura has received research support from Epilepsy Foundation of America . The institution of Dr. Moura has received research support from NIH - NIA and NINDS. Dr. Moura has received personal compensation in the range of $50,000-$99,999 for serving as a Expert Advisor with Epilepsy Foundation .
Cristiane R. Afonso, MD	No disclosure on file
Michal Szulc	No disclosure on file
Christopher Olm	No disclosure on file
Marilyn Matthew	No disclosure on file
Donald S. McCorquodale III, MD, PhD	No disclosure on file
Quang D. Vu, MD	No disclosure on file
Haluk Topaloglu, MD	No disclosure on file
Joseph Duffy	The institution of Joseph Duffy has received research support from NIH. Joseph Duffy has received publishing royalties from a publication relating to health care.
Mohammed A. Hussain, MD	No disclosure on file
Jonathan Graff-Radford, MD, F�鶹��ýӳ��	Dr. Graff-Radford has received personal compensation for serving as an employee of Mayo Clinic. Dr. Graff-Radford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS/NIH. Dr. Graff-Radford has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Graff-Radford has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Open evidence . The institution of Dr. Graff-Radford has received research support from NIH. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Cognition therapeutics. Dr. Graff-Radford has received personal compensation in the range of $5,000-$9,999 for serving as a Faculty Member with IMPACT AD .
Kristen Dams-O'Connor, PhD	Dr. Dams-O'Connor has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Various law firms. The institution of Dr. Dams-O'Connor has received research support from NIH. The institution of Dr. Dams-O'Connor has received research support from Department of Defense. The institution of Dr. Dams-O'Connor has received research support from National Institute on Disability Independent Living and Rehabilitation Research. The institution of Dr. Dams-O'Connor has received research support from Patient Reported Outcomes Research Institute.
Jon Williams, DO, PhD	Dr. Williams has nothing to disclose.
Richard L. Yates	No disclosure on file
Roberta Frigerio, MD	Dr. Frigerio has nothing to disclose.
Siddhart K. Mehta, MD	Dr. Mehta has nothing to disclose.
Kiran M. Kanth, MD	Dr. Kanth has nothing to disclose.
Alvino Bisecco	Alvino Bisecco has nothing to disclose.
Mehmet Yucel, MD	No disclosure on file
Jay Pathmanathan, MD, PhD	No disclosure on file
Abhishek Lunagariya, MD	No disclosure on file
Hakan Akgun	No disclosure on file
Wamda Ahmed, MD	No disclosure on file
Lutz Harms	No disclosure on file
Junaid H. Siddiqui, MD	Dr. Siddiqui has nothing to disclose.
Victor Calil da Silveira, MD	No disclosure on file
Hannah Homafar, MD	No disclosure on file
Augusto A. Miravalle, MD, F�鶹��ýӳ��	Dr. Miravalle has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Miravalle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Miravalle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Miravalle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Miravalle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for BMS. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for TG therapeutics. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Miravalle has received research support from Genzyme. The institution of Dr. Miravalle has received research support from EMD Serono. The institution of Dr. Miravalle has received research support from Alexion.
Fermina A. Pirmohamed, MD	No disclosure on file
Huimahn A. Choi, MD	The institution of Dr. Choi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Grace Therapeutics.
Aliza B. Ben-Zacharia, PhD, DNP, ANP, F�鶹��ýӳ��	Ms. Ben-Zacharia has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Ms. Ben-Zacharia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Ms. Ben-Zacharia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Greenwich Biosciences. Ms. Ben-Zacharia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Theraputics. The institution of Ms. Ben-Zacharia has received research support from Biogen. The institution of Ms. Ben-Zacharia has received research support from Greenwich Biosciences.
Jennifer Waldron, DO	Dr. Waldron has nothing to disclose.
Lisena Hasanaj	Ms. Hasanaj has nothing to disclose.
Philip Chang, MD	No disclosure on file
Luis Guada-Delgado, MD	Dr. Guada-Delgado has nothing to disclose.
Hyun J. Cho, MD	Dr. Cho has nothing to disclose.
Swathi Kondapalli, MD	Dr. Kondapalli has nothing to disclose.
Rachel P. Guimaraes, PT	Ms. Guimaraes has nothing to disclose.
Joel H. Torres, MD	No disclosure on file
Handan Ozisik Karaman	No disclosure on file
Peter Z. Yan, MD, MS	Dr. Yan has nothing to disclose.
Noushin Jazebi, MD	Dr. Jazebi has nothing to disclose.
AmirHussein Abdolalizadeh	No disclosure on file
Vishal Jani, MD	Dr. Jani has nothing to disclose.
David H. Dennison, MD, F�鶹��ýӳ��	No disclosure on file
Anna Mrelashvili, MD	No disclosure on file
Mary E. Richert	No disclosure on file
Yu-Ting Chen, MD	Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam.
Proleta Datta, MD	Dr. Datta has nothing to disclose.
Renxin Chu	Dr. Chu has nothing to disclose.
Alaa F. Khayat, MBBS	No disclosure on file
Daniel S. Vitantonio, MD	No disclosure on file
Olivier Stevens, MD	No disclosure on file
Kevin N. Ramdas, MD	No disclosure on file
Charenya Anandan, MD	Dr. Anandan has nothing to disclose.
Jefferson Becker, MD, PhD	Dr. Becker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMGEN. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ASTRAZENECA. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MERCK. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ROCHE. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AMGEN. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MERCK. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ASTRAZENRCA. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMS.
Luiza G. Piovesana, MD	No disclosure on file
Rejo Cherian, MD	Dr. Cherian has nothing to disclose.
Fawad Yousuf, MBBS	Dr. Yousuf has nothing to disclose.
Christa Watson	No disclosure on file
Karina L. Pires, MD	Dr. Pires has nothing to disclose.
John Mariani	No disclosure on file
Anuschka Grobelny	No disclosure on file
Daniel Korya, MD	No disclosure on file
Christina M. Dheel	No disclosure on file
Ihtesham Qureshi, MD	No disclosure on file
Manmeet Kaur, MBBS	Dr. Kaur has nothing to disclose.
Keren Regev, MD	Dr. Regev has nothing to disclose.
Erika Silverman	Ms. Silverman has nothing to disclose.
Thomas Finnegan, Jr., PhD	Dr. Finnegan has nothing to disclose.
Meryem Tuba Goksungur	No disclosure on file
Francis Odiase, MBBS	No disclosure on file